header logo image


Page 675«..1020..674675676677..680690..»

Top 10 Destinations for Stem Cell Therapy around the World

February 20th, 2020 12:41 am

Top 10 Destinations for Stem Cell Therapy Around the World

Stem Cell Therapy has made tremendous progress over the past decade. The years of approved clinical trials have shown that stem cell therapy works for certain conditions. Patients should understand that although stem cell therapy can do wonders for some diseases and illnesses, it is not for everything and everyone.

Before choosing to undergo stem cell therapy, patients should undergo a thorough research about the viability of the treatment in a certain country. Unfortunately, there are many clinics which state that they are accredited and that their treatment is approved, only to attract patients and money. Stem cell therapy can be categorized into:

Such a clinical trial program costs millions of dollars, therefore only a few accredited institutions and centers had the possibility to undergo such programs.

Competent physicians working in accredited centers can offer non-approved stem cell therapies, as long as the patient is informed about the risks and the lack of scientific support.

Stem cell therapy can be offered by clinics with no accreditation and by physicians with questionable competency. They are the ones who do exaggerated promotional claims about the efficacy and safety of stem cell therapy, which has no scientific backing.

Studies made so far suggest that stem cells have the potential of developing into different types of cells and so repair the tissue and organs affected by various medical conditions. There are hundreds of different stem cells in our bodies, which are formed at different times in our lives and with different purposes. The embryonic stem cells are found only in the early stages of development, while adult stem cells develop and remain in our bodies the entire life.

Stem cell therapy gives hope where mainstream medical science fails to offer results. So far, the most common stem cell therapy is blood stem cell transplantation for conditions and diseases of the blood, the immune system or to restore the blood after treatments for certain cancer types. Some injuries or diseases of the bone, cornea or skin can be treated using grafted tissue which depends on stem cells from these parts of the body. But people should understand that like any other type of treatment, stem cell therapy can have side effects, and these can vary from individual to individual.

As people will try anything to see at least a slight improvement in their health or their dear ones, more and more are flocking to other countries and to clinics which promote safe and successful stem cell therapy for a multitude of serious conditions. Stem Cell Tourism, as it is called, is in a continuous expansion as patients want to try the promising therapy. But which are the best destinations for stem cell therapy?

South Korea has made tremendous progress in stem cell research, thanks to the country's flexible policies in this matter. Scientists have been able to develop stem cells which genetically match patients of all genders, ages, and races, which means that they can produce stem cells that fit each individual's needs and with a lower risk of rejection. South Korea might soon get to the forefront of stem cell research.

Stem Cell Clinic:Yonsei Sarang Hospital

Mexico is a popular destination among medical touristswith plenty of stem cell research centers. Over the years the country has attracted top scientists from all over the world, offering them a host of incentives and the authorization to use embryos for research. This has helped the country to become one of the top stem cell destinations.

Stem Cell Clinic:MexStemCells Clinic

China

China, world-famous for its acupuncture and traditional Chinese medicine, plans to become a leader in stem cell research and development. In 2012, the Ministry of Health and the Ministry of Science started to evaluate all stem cell centers that were functioning illegally. This is of utmost importance for future medical tourists who will seek approved and safe stem cell therapy in China.

Stem Cell clinic: Beijing Puhua International Hospital

It has been years since patients from the US and Canada have started choosing this destination to get stem cell therapy for serious medical conditions such as paralysis, autism or cerebral palsy. Mexico continues to make tremendous progress in this area and provide safe stem cell therapy.

Stem Cell clinics: Progencell-Stem Cell Therapies

Germany continues to attract patients coming from all over the world for stem cell therapy. The country is known as Europe's Stem Cell hub, thanks to the tremendous progress made in the Adult Stem Cell research and development.

Stem Cell clinic: German International Clinic

Stem Cell therapy in Ukraine has helped hundreds of patients suffering from cirrhosis, pancreatic necrosis, burn disease, hepatitis, diabetes, critical lower limb ischemia and multiple sclerosis. The positive results of the therapy, continue to attract international patients.

Stem cell clinics: EmCell Clinic, Unique Cell Treatment Clinic

Austria is another destination preferred by medical tourists for stem cell therapy. Stem cell therapy in Austria has offered a chance to a normal life to patients suffering from Diabetes, Eye Diseases, Neurological Diseases, Gonarthritis or Peripheral vascular disease.

Stem Cell clinic: Institute for Regenerative Medicine

The Caribbean Islandsis fast-tracking stem cell research and development with new approaches being tested by renowned scientists and physicians. Patientsfrom Europe, Asia, and the Middle East come here to take advantage of the benefits offered by stem cell therapy.

Stem Cell Clinic: Garm Clinic

Another stem cell therapy leader in Asia is Thailand, a country which, for the past few years has taken stem cell research to the next level by producing cardiac muscle from human embryonic stem cells, successfully using adult stem cells to treat arthritis and discovering a method to extract stem cells from a human amniotic fluid.

Stem Cell Clinic:StemCells21

Although stem cell therapy might seem for many the last hope, we advise those who begin this journey to look for and seek help from specialists in this type of medical procedure. Experts will help you choose a safe medical destination and a high-quality hospital. Most of all you must understand that stem cell therapy can help some patients, but never cures them.

Being informed and doing a thorough research about what destination, clinic, and doctor to choose is a must when taking such a decision. Get as much information as you can about the center where you plan to undergo the treatment, try to get real patients testimonials, clinical data evaluation, find out about the centers' and doctors' credentials, detailed evaluation of the procedure they use, what methods and types of stem cells they provide, the real cost of the treatment with all expenditures included (airplane, accommodation, meals, hospital and other fees, etc).

By getting informed you will feel more secure, andtraveling abroad for medical carewill be a positive life-changing experience.

PlacidWay can offer you all the information you need for a successful medical experience overseas. Contact us and get more information about any Stem Cell Therapy on our website.Do not hesitate to contact us!

Disclaimer

Stem Cell Therapy is still an experimental treatment. Any information related to Stem Cell Therapy provided on this website is for educational purposes only. It is not intended to either replace a consultation with a licensed physician or be construed as medical advice or any emergency health need you may be experiencing.

Read more from the original source:
Top 10 Destinations for Stem Cell Therapy around the World

Read More...

Building a ‘doomsday vault’ to save the kangaroo and koala from extinction – CNET

February 20th, 2020 12:41 am

The road into Batlow is littered with the dead.

In the smoky, gray haze of the morning, it's hard to make out exactly what Matt Roberts' camera is capturing. Roberts, a photojournalist with the Australian Broadcasting Corporation, keeps his lens focused on the road as he rolls into the fire-ravaged town 55 miles west of Canberra, Australia's capital. At the asphalt's edge, blackened livestock carcasses lie motionless.

The grim scene, widely shared on social media, is emblematic of the impact the 2019-20 bushfire season has had on Australia's animal life. Some estimates suggest "many, many billions" of animals have been killed, populations of endemic insects could be crippled and, as ash washes into riverways, marine life will be severely impacted. The scale of the bushfires is so massive, scientists are unlikely to know the impact on wildlife for many years.

But even before bushfires roared across the country, Australia's unique native animals were in a dire fight for survival. Habitat destruction, invasive species, hunting and climate change have conspired against them. Populations of native fauna are plummeting or disappearing altogether, leaving Australia with an unenviable record: It has the highest rate of mammal extinctions in the world.

A large share of Australia's extinctions have involved marsupials -- the class of mammals that includes the nation's iconic kangaroos, wallabies, koalas and wombats. A century ago, the Tasmanian tiger still padded quietly through Australia's forests. The desert rat-kangaroo hopped across the clay pans of the outback, sheltering from the sun in dug-out nests.

Now they're gone.

Australia's 2019-20 bushfire season has been devastating for wildlife.

In a search for answers to the extinction crisis, researchers are turning to one lesser-known species, small enough to fit in the palm of your hand: the fat-tailed dunnart. The carnivorous mouse-like marsupial, no bigger than a golf ball and about as heavy as a toothbrush, has a tiny snout, dark, bulbous eyes and, unsurprisingly, a fat tail. It's Baby Yoda levels of adorable -- and it may be just as influential.

Mapping the dunnart's genome could help this little animal become the marsupial equivalent of the lab mouse -- a model organism scientists use to better understand biological processes, manipulate genes and test new approaches to treating disease. The ambitious project, driven by marsupial geneticist Andrew Pask and his team at the University of Melbourne over the last two years, will see scientists take advantage of incredible feats of genetic engineering, reprogramming cells at will.

It could even aid the creation of a frozen Noah's Ark of samples: a doomsday vault of marsupial cells, suspended in time, to preserve genetic diversity and help prevent further decline, bringing species back from the brink of extinction.

If that sounds far-fetched, it isn't. In fact, it's already happening.

Creating a reliable marsupial model organism is a long-held dream for Australian geneticists, stretching back to research pioneered by famed statistician Ronald Fisher in the mid-20th century. To understand why the model is so important, we need to look at the lab mouse, a staple of science laboratories for centuries.

"A lot of what we know about how genes work, and how genes work with each other, comes from the mouse," says Jenny Graves, a geneticist at La Trobe University in Victoria, Australia, who has worked with marsupials for five decades.

The mouse is an indispensable model organism that shares many genetic similarities with humans. It has been key in understanding basic human biology, testing new medicines and unraveling the mysteries of how our brains work. Mice form such a critical part of the scientific endeavor because they breed quickly, have large litters, and are cheap to house, feed and maintain.

The lab mouse has been indispensable in understanding physiology, biology and genetics.

In the 1970s, scientists developed a method to insert new genes into mice. After a decade of refinement, these genetically modified mice (known as "transgenic mice") provided novel ways to study how genes function. You could add a gene, turning its expression up to 11, or delete a gene entirely, shutting it off. Scientists had a powerful tool to discover which genes performed the critical work in reproduction, development and maturation.

The same capability does not exist for marsupials. "At the moment, we don't have any way of manipulating genes in a devil or a kangaroo or a possum," says Graves. Without this capability, it's difficult to answer more pointed questions about marsupial genes and how they compare with mammal genes, like those of mice and humans.

So far, two marsupial species -- the Tammar wallaby and the American opossum -- have been front and center of research efforts to create a reliable model organism, but they both pose problems. The wallaby breeds slowly, with only one baby every 18 months, and it requires vast swaths of land to maintain.

The short-tailed opossum might prove an even more complicated case. Pask, the marsupial geneticist, says the small South American marsupial is prone to eating its young, and breeding requires researchers to sift through hours of video footage, looking for who impregnated whom. Pask also makes a patriotic jab ("they're American so we don't like them") and says their differences from Australian marsupials make them less useful for the problems Australian species face.

But the dunnart boasts all the features that make the mouse such an attractive organism for study: It is small and easy to house, breeds well in captivity and has large litters.

"Our little guys are just like having a mouse basically, except they have a pouch," Pask says.

Pask (front) and Frankenberg inspect some of their dunnarts at the University of Melbourne.

A stern warning precedes my first meeting with Pask's colony of fat-tailed dunnarts.

"It smells like shit," he says. "They shit everywhere."

I quickly discover he's right. Upon entering the colony's dwellings on the third floor of the University of Melbourne's utilitarian BioSciences building, you're punched in the face by a musty, fecal smell.

Pask, a laid-back researcher whose face is almost permanently fixed with a smile, and one of his colleagues, researcher Stephen Frankenberg, appear unfazed by the odor. They've adapted to it. Inside the small room that houses the colony, storage-box-cages are stacked three shelves high. They're filled with upturned egg cartons and empty buckets, which work as makeshift nests for the critters to hide in.

Andrew Pask

Frankenberg reaches in without hesitation and plucks one from a cage -- nameless but numbered "29" -- and it hides in his enclosed fist before peeking out of the gap between his thumb and forefinger, snout pulsing. As I watch Frankenberg cradle it, the dunnart seems curious, and Pask warns me it's more than agile enough to manufacture a great escape.

In the wild, fat-tailed dunnarts are just as inquisitive and fleet-footed. Their range extends across most of southern and central Australia, and the most recent assessment of their population numbers shows they aren't suffering population declines in the same way many of Australia's bigger marsupial species are.

Move over, Baby Yoda.

As I watch 29 scamper up Frankenberg's arm, the physical similarities between it and a mouse are obvious. Pask explains that the dunnart's DNA is much more closely related to the Tasmanian devil, an endangered cat-sized carnivore native to Australia, than the mouse. But from a research perspective, Pask notes the similarities between mouse and dunnart run deep -- and that's why it's such an important critter.

"The dunnart is going to be our marsupial workhorse like the mouse is for placental mammals," Pask says.

For that to happen, Pask's team has to perfect an incredible feat of genetic engineering: They have to learn how to reprogram its cells.

To do so, they collect skin cells from the dunnart's ear or footpad and drop them in a flask where scientists can introduce new genes into the skin cell. The introduced genes are able to trick the adult cell, convincing it to become a "younger," specialized cell with almost unlimited potential.

The reprogrammed cells are known as "induced pluripotent stem cells," or iPS cells, and since Japanese scientists unraveled how to perform this incredible feat in 2006, they have proven to be indispensable for researchers because they can become any cell in the body.

"You can grow them in culture and put different sorts of differentiation factors on them and see if they can turn into nerve cells, muscle cells, brain cells, blood vessels," Pask explains. That means these special cells could even be programmed to become a sperm or an egg, in turn allowing embryos to be made.

Implanting the embryo in a surrogate mother could create a whole animal.

It took about 15 minutes to get this dunnart to sit still.

Although such a technological leap has been made in mice, it's still a long way from fruition for marsupials. At present, only the Tasmanian devil has had iPS cells created from skin, and no sperm or egg cells were produced.

Pask's team has been able to dupe the dunnart's cells into reverting to stem cells -- and they've even made some slight genetic tweaks in the lab. But that's just the first step.

He believes there are likely to be small differences between species, but if the methodology remains consistent and reproducible in other marsupials, scientists could begin to create iPS cells from Australia's array of unique fauna. They could even sample skin cells from wild marsupials and reprogram those.

Doing so would be indispensable in the creation of a biobank, where the cells would be frozen down to -196 degrees Celsius (-273F) and stored until they're needed. It would act as a safeguard -- a backup copy of genetic material that could, in some distant future, be used to bring species back from the edge of oblivion, helping repopulate them and restoring their genetic diversity.

Underneath San Diego Zoo's Beckman Center for Conservation Research lies the Frozen Zoo, a repository of test tubes containing the genetic material of over 10,000 species. Stacked in towers and chilled inside giant metal vats, the tubes contain the DNA of threatened species from around the world, suspended in time.

It's the largest wildlife biobank in the world.

"Our goal is to opportunistically collect cells ... on multiple individuals of as many species as we can, to provide a vast genetic resource for research and conservation efforts," explains Marlys Houck, curator at the Frozen Zoo.

The Zoo's efforts to save the northern white rhino from extinction have been well publicized. Other research groups have been able to create a northern white rhino embryo in the lab, combining eggs of the last two remaining females with frozen sperm from departed males. Scientists propose implanting those embryos in a surrogate mother of a closely related species, the southern white rhino, to help drag the species back from the edge of oblivion.

For the better part of a decade, conservationists have been focused on this goal, and now their work is paying off: In the "coming months," the lab-created northern white rhino embryo will be implanted in a surrogate.

Sudan, the last male northern white rhinoceros, was euthanized in 2018.

Marisa Korody, a conservation geneticist at the Frozen Zoo, stresses that this type of intervention was really the last hope for the rhino, a species whose population had already diminished to just eight individuals a decade ago.

"We only turn to these methods when more traditional conservation methods have failed," she says.

In Australia, researchers are telling whoever will listen that traditional conservation methods are failing.

"We've been saying for decades and decades, many of our species are on a slippery slope," says John Rodger, a marsupial conservationist at the University of Newcastle, Australia, and CEO of the Fauna Research Alliance, which has long advocated for the banking of genetic material of species in Australia and New Zealand.

In October, 240 of Australia's top scientists delivered a letter to the government detailing the country's woeful record on protecting species, citing the 1,800 plants and animals in danger of extinction, and the "weak" environmental laws which have been ineffective at keeping Australian fauna alive.

Institutions around Australia, such as Taronga Zoo and Monash University, have been biobanking samples since the '90s, reliant on philanthropic donations to stay online, but researchers say this is not enough. For at least a decade, they've been calling for the establishment of a national biobank to support Australia's threatened species.

John Rodger

"Our real problem in Australia ... is underinvestment," Rodger says. "You've got to accept this is not a short-term investment."

The current government installed a threatened-species commissioner in 2017 and committed $255 million ($171 million in US dollars) in funding to improve the prospects of 20 mammal species by 2020. In the most recent progress report, released in 2019, only eight of those 20 were identified as having an "improved trajectory," meaning populations were either increasing faster or declining slower compared to 2015.

A spokesperson for the commissioner outlined the $50 million investment to support immediate work to protect wildlife following the bushfires, speaking to monitoring programs, establishment of "insurance populations" and feral cat traps. No future strategies regarding biobanking were referenced.

Researchers believe we need to act now to preserve iconic Australian species like the koala.

In the wake of the catastrophic bushfire season and the challenges posed by climate change, Australia's extinction crisis is again in the spotlight. Koalas are plastered over social media with charred noses and bandaged skin. On the front page of newspapers, kangaroos bound in front of towering walls of flame.

Houck notes that San Diego's Frozen Zoo currently stores cell lines "from nearly 30 marsupial species, including koala, Tasmanian devil and kangaroo," but that's only one-tenth of the known marsupial species living in Australia today.

"Nobody in the world is seriously working on marsupials but us," Rodger says. "We've got a huge interest in maintaining these guys for tourism, national icons... you name it."

There's a creeping sense of dread in the researchers I talk to that perhaps we've passed a tipping point, not just in Australia, but across the world. "We are losing species at an alarming rate," says Korody from the Frozen Zoo. "Some species are going extinct before we even know they are there."

With such high stakes, Pask and his dunnarts are in a race against time. Perfecting the techniques to genetically engineer the tiny marsupial's cells will help enable the preservation of all marsupial species for generations to come, future-proofing them against natural disasters, disease, land-clearing and threats we may not even be able to predict right now.

Pask reasons "we owe it" to marsupials to develop these tools and, at the very least, biobank their cells if we can't prevent extinction. "We really should be investing in this stuff now," he says. He's optimistic.

In some distant future, years from now, a bundle of frozen stem cells might just bring the koala or the kangaroo back from the brink of extinction.

And for that, we'll have the dunnart to thank.

Originally published Feb. 18, 5 a.m. PT.

Continue reading here:
Building a 'doomsday vault' to save the kangaroo and koala from extinction - CNET

Read More...

Build a & # 39; vault of the end of the world & # 39; to save the kangaroo and the koala from extinction – NewsDio

February 20th, 2020 12:41 am

The road to Batlow is full of dead.

In the gray, smoky mist of the morning, it is difficult to distinguish exactly what Matt Roberts' camera captures. Roberts, a graphic reporter for the Australian Broadcasting Corporation, keeps his lens focused on the road while rolling towards the devastated by fire 55 miles west of Canberra, the capital of Australia. On the edge of the asphalt, the blackened carcasses lie motionless.

The grim scene widely shared on social networks, is emblematic of the impact that the forest fire season 2019-20 has had on the animal life of Australia. Some estimates suggest that "many, billions" of animals have been killed, endemic insect populations could be crippled and, as the ashes go down to the waterways, marine life will be severely affected. The scale of forest fires is so large that scientists are unlikely to know the impact on wildlife for many years.

But even before wildfires roared across the country, the only animals native to Australia were in a terrible struggle for survival. Habitat destruction, invasive species, hunting and climate change have conspired against them. Native wildlife populations are plummeting or disappearing altogether, leaving Australia with an unenviable record: it has the highest rate of mammalian extinctions in the world.

A large part of the extinctions in Australia have involved marsupials, the kind of mammals that include kangaroos, wallabies, koalas and the nation's iconic wombats. A century ago, the Tasmanian Tiger He was still walking quietly through the forests of Australia. The desert rat kangaroo leapt through the clay containers inside, taking refuge from the sun in excavated nests.

Now they are gone.

Australia's 2019-20 forest fire season has been devastating for wildlife.

John Moore / Getty

In a search for answers to the extinction crisis, researchers are turning to a lesser-known species, small enough to fit in the palm of their hand: the fat-tailed dunnart. The mouse-shaped carnivorous marsupial, no bigger than a golf ball and almost as heavy as a toothbrush, has a small snout, dark, bulbous eyes and, as expected, a fat tail. Their Baby yoda adorable levels, and can be so influential.

The dunnart genome mapping could help this small animal to become the marsupial equivalent of the laboratory mouse, a model organism that scientists use to better understand biological processes, manipulate genes and try new approaches to treat the disease. The ambitious project, driven by the marsupial geneticist Andrew Pask and his team at the University of Melbourne over the past two years, will see scientists take advantage of the incredible feats of genetic engineering, reprogramming the cells at will.

It could even help the creation of a frozen Noah's ark of samples: a vault at the end of the world of marsupial cells, suspended in time, to preserve genetic diversity and help prevent further deterioration, returning species to the edge of the extinction

If that sounds exaggerated, it is not. In fact, it is already happening.

The creation of a reliable marsupial model organism is a long-standing dream for Australian geneticists, dating back to research initiated by the famous statistician Ronald Fisher in the mid-20th century. To understand why the model is so important, we must look at the laboratory mouse, a staple of science labs for centuries.

"A lot of what we know about how genes work and how genes work with each other, comes from the mouse," says Jenny Graves, a geneticist at La Trobe University in Victoria, Australia, who has worked with marsupials for five decades.

The mouse is an indispensable model organism that shares many genetic similarities with humans. It has been key in Understand basic human biology, try new medications and unravel the mysteries of how our brains work. Mice form such an important part of the scientific effort because they reproduce quickly, have large litters and are economical to house, feed and maintain.

The laboratory mouse has been indispensable for understanding physiology, biology and genetics.

Getty / Picture Alliance

In the 1970s, scientists developed a method to insert new genes into mice. After a decade of refinement, these genetically modified mice (known as "transgenic mice") provided new ways to study how genes work. You could add a gene, changing its expression to 11, or remove a gene completely, turning it off. The scientists had a powerful tool to discover which genes performed the critical work in reproduction, development and maturation.

The same capacity does not exist for marsupials. "At the moment, we have no way of manipulating genes in a demon, a kangaroo or an opossum," says Graves. Without this ability, it is difficult to answer more specific questions about marsupial genes and how they compare to mammalian genes, such as mice and humans.

So far, two species of marsupials, the Tammar wallaby and the American opossum, have been the focus of research efforts to create a reliable model organism, but both pose problems. The wallaby reproduces slowly, with only one baby every 18 months, and requires vast tracts of land to support itself.

Short-tailed possum could be an even more complicated case. Pask, the marsupial geneticist, says that the little South American marsupial is prone to eat his young, and the young requires researchers to examine hours of video, looking for who impregnated who. Pask also makes a patriotic jab ("they are Americans, so we don't like them") and says that their differences with Australian marsupials make them less useful for the problems facing Australian species.

But the dunnart has all the features that make the mouse such an attractive organism for the study: it is small and easy to accommodate, reproduces well in captivity and has large litters.

"Our little boys are like having a mouse basically, except they have a bag," says Pask.

Pask (front) and Frankenberg inspect some of their dunnarts at the University of Melbourne.

Jackson Ryan / CNET

A severe warning precedes my first encounter with Pask's fat-tailed dunnarts colony.

"It smells like shit," he says. "They shit everywhere."

I quickly discover that he is right. Upon entering the homes of the colony on the third floor of the utilitarian BioSciences building at the University of Melbourne, a musty smell and feces hit you in the face.

Pask, a relaxed investigator whose face is almost permanently fixed with a smile, and one of his colleagues, researcher Stephen Frankenberg, is not frightened by the smell. They have adapted to that. Inside the small room that houses the colony, the storage cages are stacked on three shelves high. They are full of cartons of overturned eggs and empty buckets, which function as makeshift nests for creatures to hide.

The dunnart will be our marsupial workhorse as the mouse for placental mammals.

Andrew Pask

Frankenberg approaches without hesitation and pulls one out of a cage, without a name but numbered "29", and hides in his clenched fist before peering through the space between his thumb and index finger, with his muzzle pressing. While I see Frankenberg cradling him, the dunnart seems curious, and Pask warns me that he is agile enough to make a great escape.

In nature, thick-tailed dunnarts are equally curious and floating-legged. Their range extends over most of southern and central Australia, and the most recent assessment of their population numbers shows that they are not suffering population declines in the same way as many of Australia's largest marsupial species.

Move aside, Baby Yoda.

Jackson Ryan / CNET

While I see 29 running around Frankenberg's arm, the physical similarities between him and a mouse are obvious. Pask explains that the DNA of the dunnart is much more related to the Tasmanian devil, a carnivore the size of an endangered cat native to Australia, than the mouse. But from a research perspective, Pask points out that the similarities between the mouse and the dunnart are deep, and that is why he is such an important creature.

"The dunnart will be our marsupial workhorse as the mouse for placental mammals," says Pask.

For that to happen, Pask's team has to perfect an incredible feat of genetic engineering: they have to learn to reprogram their cells.

To do this, they collect cells from the skin of the ear or the foot pad of the dunnart and place them in a flask where scientists can introduce new genes into the skin cell. The introduced genes can deceive the adult cell, convincing it to become a specialized "younger" cell with almost unlimited potential.

Reprogrammed cells are known as "induced pluripotent stem cells" or iPS cells, and since Japanese scientists unraveled how to perform this incredible feat in 2006, they have proven indispensable for researchers because they can become none cell in the body

"You can grow them in culture and put different types of differentiation factors on them and see if they can become nerve cells, muscle cells, brain cells, blood vessels," explains Pask. That means that these special cells could even be programmed to become a sperm or an egg, allowing embryos to occur.

Implanting the embryo in a surrogate mother could create a whole animal

It took about 15 minutes to make this dunnart stand still.

Jackson Ryan / CNET

Although there has been a great technological leap in mice, it is still a long way from fruiting the marsupials. Currently, only the Tasmanian devil has created iPS cells from the skin, and no sperm or ovules have been produced.

Pask's team has been able to trick dunnart cells into stem cells, and they have even made some slight genetic adjustments in the laboratory. But that is only the first step.

He believes there are likely to be small differences between species, but if the methodology is still consistent and reproducible in other marsupials, scientists could begin to create iPS cells from the unique Australian fauna variety. They could even take samples of wild marsupial skin cells and reprogram them.

Doing so would be indispensable in creating a biobank, where cells would freeze at -196 degrees Celsius (-273 F) and store until needed. It would act as a safeguard: a backup copy of the genetic material that could, in the distant future, be used to bring species back to the brink of oblivion, helping to repopulate them and restore their genetic diversity.

Under the Beckman Center for the Conservation Research of the San Diego Zoo is the Frozen Zoo, a repository of test tubes containing the genetic material of more than 10,000 species. Stacked in towers and refrigerated inside giant metal vats, the tubes contain the DNA of threatened species from around the world, suspended in time.

It is the largest wildlife biobank in the world.

"Our goal is to collect cells opportunistically in multiple individuals of as many species as we can, to provide a vast genetic resource for research and conservation efforts," explains Marlys Houck, curator of the frozen zoo.

The zoo's efforts to save the northern white rhino from extinction have been well publicized. Other research groups have been able to create a northern white rhino embryo in the laboratory, combining ovules from the last two remaining females with frozen sperm from deceased males. The scientists propose to implant these embryos in a surrogate mother of a closely related species, the southern white rhinoceros, to help drag the species towards the edge of oblivion.

For most of a decade, conservationists have focused on this goal, and now their work is paying off: in the "coming months," the northern white rhino embryo created in the laboratory will be implanted in a substitute.

Sudan, the last white rhino of the male north, was sacrificed in 2018.

Tony Karumba / Getty

Marisa Korody, a conservation geneticist at the frozen zoo, emphasizes that this type of intervention was really the last hope for the rhinoceros, a species whose population had already declined to only eight individuals a decade ago.

"We only resort to these methods when the more traditional conservation methods have failed," she says.

In Australia, researchers tell whoever hears that traditional conservation methods are failing.

"We've been saying for decades and decades, many of our species are on a slippery slope," says John Rodger, a marsupial conservationist at the University of Newcastle, Australia, and CEO of the Wildlife Research Alliance, who has long advocated time by the bank of species genetic material in Australia and New Zealand.

In October, 240 of Australia's top scientists delivered a letter to the government detailing the country's unfortunate history of species protection, citing 1,800 plants and animals in danger of extinction, and "weak" environmental laws that have not been effective in keeping Australian wildlife alive. .

Australian institutions, such as the Taronga Zoo and Monash University, have been samples of biobanks since the 1990s, which rely on philanthropic donations to stay online, but researchers say this is not enough. For at least a decade, they have been calling for the establishment of a national biobank to support threatened species in Australia.

No one in the world is working seriously on marsupials except us.

John rodger

"Our real problem in Australia is the lack of investment," says Rodger. "You have to accept that this is not a short-term investment."

The current government installed a commissioner of endangered species in 2017 and committed $ 255 million ($ 171 million in US dollars) in funds to improve the prospects of 20 mammal species by 2020. In the most recent progress report, published in 2019, only eight of those were identified that 20 had an "improved trajectory", which means that populations increased faster or decreased more slowly compared to 2015.

A spokesman for the commissioner described the $ 50 million investment to support immediate work to protect wildlife after forest fires, talking about monitoring programs, establishing "insurance populations" and traps for wild cats. No reference was made to future strategies regarding biobank.

Researchers believe that we must act now to preserve iconic Australian species such as koala.

Fairfax Media / Getty

Following the catastrophic season of forest fires and the challenges posed by climate change, Australia's extinction crisis is once again in the spotlight. Koalas are covered in social networks with charred noses and bandaged skin. On the front page of the newspapers, kangaroos tied in front of imposing walls of flame.

Houck notes that the San Diego frozen zoo currently stores cell lines "of almost 30 species of marsupials, including koala, Tasmanian devil and kangaroo," but that is only one tenth of the known marsupial species that live in Australia today in day.

"No one in the world is working seriously on marsupials except us," says Rodger. "We have a keen interest in keeping these guys for tourism, national icons whatever."

The researchers I speak with feel a growing sense of fear that perhaps we have passed a turning point, not only in Australia, but throughout the world. "We are losing species at an alarming rate," says Korody of the frozen zoo. "Some species are becoming extinct even before we know they are there."

With so much at stake, Pask and his dunnarts are in a race against time. Improving the techniques to genetically design the small cells of the marsupial will help allow the preservation of all species of marsupials for generations to come, future-proof against natural disasters, diseases, clearings and threats that we cannot even predict at this time.

Pask reasons "we owe it" to the marsupials to develop these tools and, at least, biobank their cells if we cannot avoid extinction. "We should really invest in these things now," he says. He is optimistic.

In the distant future, within years, a package of frozen stem cells could bring the koala or kangaroo back to the brink of extinction.

And for that, we will have the dunnart to thank.

Originally published on February 18 at 5 a.m. PT.

Here is the original post:
Build a & # 39; vault of the end of the world & # 39; to save the kangaroo and the koala from extinction - NewsDio

Read More...

‘A stronger B.C., for everyone’: Read the full text of the B.C. Budget 2020 speech – CTV News

February 20th, 2020 12:41 am

VCTORIA -- B.C. Finance Minister Carole James delivered the NDP's third balanced budget in a row Tuesday. Below is the text of her budget speech in its entirety:

Id like to begin by acknowledging that we are on the traditional territory of the Songhees and Esquimalt Nations and I want to give a warm welcome to everyone here today. A budget is built with the work and input of many thanks to all the staff in the Ministry of Finance and my office for their extraordinary efforts.

Thank you to everyone who wrote and took part in the Select Standing Committee on Finances budget consultations and thank you to the many people who have shared their ideas and hopes for the future of our province. Working together will help us build a stronger B.C. for everyone. Thats what Budget 2020 is all about.

Its about the fundamental changes our government has been making for the people of British Columbia. Its about continuing to fix the problems facing families today. And its about delivering the results that keep us moving forward together. The changes we have made are all about making lives better today and creating opportunities that last a lifetime opportunities to put down roots, contribute to your community, and have a job that provides a good quality of life.

These are the things that drive us and my family is no exception. In the 1950s, my grandparents left England and moved to Saskatchewan with my mum. Like so many others who immigrated to Canada, they left the only home they had ever known in search of a better life for their family.

Times were tough, money was tight. My grandmother soon found a job at the local hospital. Together, she and my grandfather worked day in and day out to put food on the table and keep a roof over our heads. For my grandparents, family was never just immediate family it was anyone in our community who needed a hand up. Over the years, our family grew to include dozens of foster kids.

Growing up alongside children of all ages and abilities showed me that while everyone has something to contribute to this world, not everyone is given the opportunity they need to make their mark. While my grandmother possessed a quiet, solid strength, my mother is the trail-blazer and fierce community advocate.

As a young single parent with two children, my mum enrolled in teachers college, about two hours away from our family home in Saskatchewan. During the week, my grandparents would take care of me and my sister, while my mum put herself through school.

Looking back, I can see the barriers she faced as a single parent to two young girls living in a small prairie town. I also recognize that access to education creates opportunities that span generations it has the power to change a family forever.

Had the door to opportunity remained closed for my mother, I have no doubt that my life would have looked very different.

These personal experiences also reflect what I have heard from so many British Columbians. People want to do for themselves; sometimes they just need a door to open for that to happen. As Finance Minister, its my job to make sure that the benefits of B.C.s strong economy are felt by everyone, not just the few at the top.

After nearly three years of choices that put people first, were starting to see the results. From new roads, hospitals, schools, and housing, to new services and job opportunities life in B.C. is getting better every day.

And our economy is stronger because we are putting B.C. on a path to a cleaner, better future. This is my third full budget as Finance Minister.

As with previous years, our government continues to work from a balanced budget. Our fiscal strategy lays out a solid plan with layers of planning and foresight. B.C. remains an economic leader in Canada. We are the only province with triple-A credit ratings from the three major international rating agencies.

We have the lowest unemployment rate in the country, and zero operating debt. Our fiscal foundation remains strong, as does our commitment to:

We know that delivering on these priorities means strong climate action, meaningful reconciliation with Indigenous peoples and a commitment to equity, diversity and inclusion.

Supported by the Confidence and Supply Agreement with the BC Green Party caucus, government is advancing these priorities.

Moving forward, together

Together, we have made a lot of progress and, today, I am presenting our plan to keep B.C. moving forward.

Budget 2020 breaks down barriers to opportunity for you, your children and your neighbours.

Budget 2020 delivers access to a good education, quality health care and vital community supports.

And Budget 2020 supports British Columbians who are working hard to get ahead by making life more affordable.

We are not here to deliver the largest surplus possible, at all costs.

The point of a budget is to plan ahead, to set priorities and to make responsible decisions that are good for people over the long term.

That is what we have done for the last two and a half years, and we cant afford to turn back.

Choosing a different path

Over the last decade our provinces economy has remained strong, but many people and communities fell further behind.

There was a bright future in British Columbia, but only for the few who could afford it. I am proud to say that, as a province, we are now on a different path. We are making different choices. And Budget 2020 backs up our choices with action. Mr. Speaker, the days of cashing in on a hot real estate market at the expense of hardworking British Columbians are done.

Instead of turning a blind eye to money laundering and the housing crisis, were acting so that everyone can afford a future in British Columbia. Money laundering in our economy must end. Our goal is to ensure balance and it is not balanced to have an economy distorted by dirty money. Budget 2020 delivers on our commitment to conduct a public inquiry and get people the answers they deserve.

Mr. Speaker, the old practice of hoarding surplus at the expense of people is over. Instead, we are choosing a balanced fiscal approach, one that maintains a reasonable surplus while investing in people. Because we understand that when the door to opportunity closes one too many times, people can lose hope. A little support can be life changing.

Building on our governments poverty reduction plan, Budget 2020 increases earnings exemptions for people receiving income and disability assistance. This gives people a chance to increase their household income, remain connected to the workforce, and build up the kind of valuable work experience that can lead to a good-paying job. And after years of cuts that hurt people most in need, Budget 2020 provides new funding for children in care and adults with diverse abilities.

A commitment to ongoing funding for the cultural connections program will provide more support for Indigenous children to stay connected with their communities and families. Mr. Speaker, in partnership with Indigenous peoples, we are choosing a more stable and prosperous path for everyone.

We got right to work with new money for language revitalization, a historic revenue-sharing agreement, and changes to the child welfare system that will keep more Indigenous children in their communities. Aboriginal friendship centres now have long-term, stable funding. And we stepped up as the first province to fund on-reserve housing in Canada.

I am proud to say that the human rights of Indigenous peoples are now enshrined in law as the Declaration on the Rights of Indigenous Peoples Act. I recognize the road ahead is not without its challenges. But if we invite the conversation and work from a place of respect, we will build a better future together. And to achieve that future, Mr. Speaker, our government is not waiting to take action on complex problems that defy simple solutions.

Our government has taken significant steps to help address sustainability at ICBC and affordability for British Columbians.

While the old government ignored the problems with auto insurance, we are transforming ICBC to make it work for you.

Instead of pushing problems down the road, we are standing up for the best interests of British Columbians.

I want to recognize that, right now, the people who depend on B.C.s forest industry are hurting. A thriving forest sector has provided good, stable jobs for many families going back generations. However, over the last number of years, the mountain pine beetle infestation, wildfires and the softwood lumber dispute have reduced timber supply and triggered a wave of mills to close their doors or scale back shifts.

These changes didnt happen overnight, but that doesnt lessen the hardship that forest workers and their families are facing right now.

We wont turn our backs on the people who have helped power our province for so long. Our governments top priority is to provide the help that people need to get on with their lives, to support their families, and to plan for a good future in our province.

Workers are now getting job placement and skills training, equipment loans for coastal logging contractors, grants for hard-hit communities, and programs to support early retirement. Investments in public infrastructure are building a better British Columbia, and wherever possible, B.C. engineered wood will serve as the foundation.

These are important steps. But a healthy and sustainable forest industry depends on bringing together industry, First Nations, unions and government to find solutions.

Budget 2020 takes another step forward with new funding to begin developing opportunities for B.C.s bio-economy and revitalization within the forest sector.

We will keep working hard to make sure that forest workers, contractors, and communities get the support they deserve.

A better future, together

Because we are all in this together. And only when we work together, will we succeed in the kind of fundamental change that provides relief from the problems facing people now and inspires hope for a better future.

A future where your opportunities are not defined by your age, income bracket or home address. Instead, our plan creates a lifetime of opportunity for everyone in British Columbia.

For my family as it does for so many others it all started with a good education. Going back to school and building up her career meant that my mother was able to put away a little money each month and build a better future for herself and our family. Growing up, we didnt always have a lot, but we had enough for both me and my sister to know that nothing was out of reach.

As Finance Minister, I am unwavering in my commitment to delivering the opportunities that our children and grandchildren deserve. But for too long, families were left to struggle as their monthly bills kept going up, while the health, education, and community supports they counted on were slashed. In a prosperous province like British Columbia, we can and must do better. And we are.

Launching this fall, the new BC Child Opportunity Benefit will help lift up thousands of kids and give them the opportunities they deserve, now and down the road. Families with one child will be eligible to receive up to $1,600 annually. For two children, that goes up to $2,600, and its up to $3,400 for three kids. People can bank on this tax-free support up until their childs eighteenth birthday. On top of the new benefit, this will be the first full year that people wont have to pay the unfair MSP premium.

Together, these two measures could save families thousands of dollars that they can put towards what really matters: setting up the next generation for success. For many, that starts with access to affordable, high-quality child care. Child care for all is closer than ever to becoming a reality in our province. Thousands of new licensed child care spaces are opening, and some parents are saving nearly $20,000 annually. Budget 2020 builds on the progress with total investments reaching $2 billion over three years for child care in British Columbia.

Child care is critical to achieving equality in the workplace, helping to close the gender pay gap, and giving more parents particularly women the opportunity to take their careers to the next level. We are also investing in B.C.s early childhood educators again, almost entirely women with more bursaries and increased wages.

Additionally, B.C.s minimum wage will rise to more than $15 per hour by 2021. For the almost 140,000 people who currently earn minimum wage, more than half of which are women, this will provide a much-needed boost.

Weve also invested over $12 million to provide more opportunities for women to become todays electricians, carpenters and heavy-duty mechanics, while opening the door for the next generation of girls.

Mr. Speaker, our government is putting children and families first. Child care for all is a fundamental change that will redefine an entirely new generation of children and their parents. Not only does quality child care give parents peace of mind, it can help provide kids with the solid start they need for a smooth transition to school.

Record investments in education mean that B.C. kids are learning in some of the smallest class sizes in a decade with more supports available for children of all ages and abilities. New schools are opening in some of our fastest growing communities, from Surrey to Fort St. John, and Chilliwack to Langley, to inspire hope, curiosity and confidence in young learners. As Finance Minister, but also as a mother and grandmother, I know the success of our province depends on giving our kids the best possible start in life.

Inside the classroom, we are supporting students with more than 4,200 teachers, including 700 new special education teachers, and nearly 200 new teacher-psychologists and counsellors. I am proud to say that Budget 2020 includes new funding of $339 million over the next three years to continue improving B.C. schools and setting students up for success.

Together, these investments add to the work already underway to strengthen our K-12 system, build better and safer schools, and prepare students for life after graduation. Mr. Speaker, we are making sure that our young people have the skills and training to excel in the economy of tomorrow.

In the next 10 years, there will be more than 800,000 job openings in health care, early childhood education, skilled trades, tech and much more. There are good things happening in our province, and we want everyone to be a part of it. That is why our government has focused on breaking down barriers and creating pathways to opportunities. Adult Basic Education and English Language Learning are now free. Twelve hundred former youth in care are now attending college, university and trade schools for free. B.C. student loans are now interest free. And were partnering with post-secondary institutions to build thousands more student housing beds. Because we want our young people to focus on gaining the skills, knowledge and experience they need to provide for themselves and help power B.C.s economy. From my own experience, I saw how being able to go to school and build up my mums career changed her and my family. As a single parent, it put her on the pathway to economic independence and opened doors for me and my sister.

At the same time, being able to rely on the support of family helped my mum overcome the obstacles that may otherwise have kept her out of school. She was able to seize the opportunity and build a better life for herself and our family.

These are the kinds of opportunities that every person and every family deserve. And as Finance Minister, this is exactly what I intend to deliver.

As part of Budget 2020, I am proud to announce the new BC Access Grant for post-secondary students. Starting in September 2020, the new BC Access Grant will provide upfront funding to more than 40,000 students who may otherwise struggle to pay for post-secondary education. Between the new access grant and the Canada Student Grant, students can receive up to $4,000 a year to help them with the cost of tuition.

And for the first time provincial grants will be available to part-time students and students enrolled in programs of less than two years. This will help people land good-paying jobs in high-demand fields like early childhood education, health care and the skilled trades.

This grant is about investing in our shared future A future where B.C.s workforce is flexible, innovative and ready to thrive in a world shaped by advancing technology, global trade and climate action.

And, I believe B.C. will rise to that challenge thanks to the passion and talents of the people who call our province home.

Building up a skilled workforce is one part of the equation. But we also need to build affordable housing to keep people in the neighbourhoods where they live, work and learn. Sweeping change is on the way thanks to the largest investment in affordable housing in B.C.s history $7 billion over 10 years to deliver 114,000 homes. In just two and a half years, almost 23,000 new homes are underway or complete throughout the province.

We started where the impact was most immediate. More than 2,000 people who were homeless now have stable housing and access to 24/7 support. And another 800 supportive homes are on the way. This years budget provides additional funding for more emergency shelter spaces, supportive homes and navigation centres to provide wraparound supports for people in need. Overall, government is delivering more than $4 billion over three years to help bring affordable housing within reach for people of all ages and income levels. We have a long way to go and we will get there in partnership with all levels of government, Indigenous peoples, not for profits and the private sector.

Mr. Speaker, our government is delivering the homes British Columbians need, along with the infrastructure and services that people count on, from our kids to our parents and grandparents. We know there is nothing more important than being able to access high-quality health care when you or your loved one needs it the most. As B.C.s population grows and ages, we need to make sure we are ready to meet the demand.

And Budget 2020 delivers. We are providing an additional $1 billion over three years for British Columbias health-care system. This new funding will help bring down surgical wait times and address the growing demand for services. Budget 2020 delivers better care for you and your family by building on the steps we have already taken to transform B.C.s health care system.

New or upgraded hospitals are coming to Fort St. James, Surrey, Williams Lake, Burnaby, Quesnel, Vancouver, Trail, Richmond, Nanaimo, North Vancouver, Dawson Creek, the Cowichan Valley and Terrace. New urgent and primary care centres are now open in Kamloops, Quesnel, Langford, Surrey, Vancouver, Nanaimo, Prince George, Burnaby, North Vancouver, Kelowna, Vernon, Maple Ridge and Pitt Meadows. And another two centres are opening soon in Victoria and East Vancouver. After years of cuts, investments in long-term care and respite services are giving seniors and their caregivers a well-deserved boost.

No one should be forced to decide between buying groceries or prescription medicine. This year marks the first anniversary of eliminating or reducing Fair Pharmacare deductibles for 240,000 families. And soon, every post-secondary student will have access to 24/7 mental-health support services. This builds on a province-wide expansion of Foundry Centres to provide youth and families with a one stop shop for mental-health and substance-use supports.

Because its crucial to reach out to people early, before challenges escalate. We know theres more to do, especially when it comes to keeping our young people healthy. As part of Budget 2020, B.C. will begin charging PST on sweetened carbonated drinks to help address the health and economic costs of these beverages.

Research shows that teens between the ages of 14 and 18 are the top consumers of pop. This is a step that health professionals and an all-party committee have long supported. Because this is about keeping young people healthy while taking in a bit of revenue to continue to pay for enhanced health care services for everyone.

An economy that works for people

We know that people work hard to build a good life for themselves and their family. And in turn, people deserve an economy that works hard for them

By delivering good, stable jobs in all corners of the province. By building a connected and resilient network of communities. And by recognizing that a prosperous future means a clean future. To do that, we need an economy that works for people. When people thrive, our economy thrives. As Finance Minister, I often speak about the importance of building a diverse, sustainable and resilient economy. But what does that mean?

I think about my own story. My grandparents were both able to find good jobs that allowed them to provide for our family. My mum was able to go back to school and build up her career because my grandparents were willing and able to look after me and my sister. To me, this gets at the heart of what resilience looks like, for families and communities. It doesnt come down to our own individual strength, but rather the strength of the community we build around us. And this comes back to the core value guiding our government. It does not come down to a choice between investing in a strong economy, a clean environment, or in the people that call this province home. Investing in people, communities, and a clean future is fundamental to building a strong and sustainable economy.

This is a significant departure from what people experienced throughout much of the past decade. While British Columbias economy remained strong, many people and communities fell further behind. Now, together, we are building a better future grounded by an economy that works for everyone, not just those at the top.

As part of Budget 2020 and our governments ongoing work to improve the services and infrastructure that we all depend on, a new tax bracket is being introduced for the top 1% of income earners in our province.

Nearly half the revenue will come from people making more than $1 million annually. This will help to deliver the infrastructure and services that create good jobs and keep B.C.s economy moving, while maintaining B.C.s tax system as one of the most competitive in the country. As Ive said before, we continue to do our part and look carefully at spending across government. This is simply part of ongoing responsible budget management.

No matter where you call home whether its our provinces north, south, east or west our plan creates opportunities for you.

I know that as proud British Columbians, there is more that unites us than divides us. We all want life to be more affordable. We all want a quality education for our kids. We all want access to health care when we need it. And we all want to feel the benefits that come with a strong provincial economy.

These are the priorities that have shaped our provinces historic capital plan. The scale of change is staggering: $18 billion worth of work is happening in all corners of the province. By building the schools, roads, hospitals, housing, post-secondary facilities and more that our growing province needs, our plan is supporting 100,000 direct and indirect jobs during construction. Together, we are building our way to a better quality of life no matter where you live.

For our urban centres, parents taking their kids to soccer practice will be able to hop on the Broadway Subway. Or, an electrician travelling from her home in Surrey to a job in New West will get where she needs to go because of the new Pattullo Bridge.

Metro Vancouver is already home to one of the top transit systems in the world. Our government is committed to building on the momentum, creating transit-oriented housing, good jobs and a path towards a cleaner future.

Looking to our rural communities, Highway 1 upgrades between Kamloops and Alberta will improve travel for locals, visitors and commercial drivers. And east of Golden, we are on the final phase of the Kicking Horse Canyon Project.

Investments in BC Transit are shortening daily commutes for people, while the BC North Bus connects our northern residents to jobs and services, along with family and friends.

After years of cuts to ferry service, our government is prioritizing coastal communities. Sailings have been added, fares have been frozen on major routes, and the seniors discount is back in effect. But infrastructure is about more than ferries, roads, bridges and transit it is also about the flow of ideas, knowledge and opportunity.

We are close to bringing our 500th connected community online. This means a digital world of opportunity is now open to people in Deka Lake, Clinton, Tofino, and Haida Gwaii.

British Columbia is growing, and we need to ramp up infrastructure investments digital and otherwise to keep goods, services, and people moving and B.C. businesses thriving. As government, we are working closely with the Business Council of British Columbia and the BC Chamber of Commerce to foster a competitive environment. And I want to say thank you to the many businesses and entrepreneurs who have chosen to set up shop in B.C.

We know that our economy must provide opportunities for businesses to succeed and they are. Named as one of 2019s top global cleantech companies, Semios gives B.C. farmers real-time data on their crops.

This kind of innovation feeds into the work of our governments Food Security Task Force, which aims to unlock the potential for agri-tech in B.C, create more jobs and reduce waste. And we are making good progress. Thanks to the hard-working people who make up B.C.s agriculture sector, 2018 was a record year for revenue. Another boost will come from new regional food hubs in Surrey, Port Alberni, Quesnel and Vancouver.

Mining, another one of B.C.s key industries, is joining forces with clean-tech to give local companies a global advantage.

As one example, Saltworks has created a new energy efficient technology that turns contaminated water from resource extraction into clean, fresh water.

In the rapidly expanding field of biotech, homegrown talent like STEMCELL Technologies is on track to create hundreds of new jobs in Burnaby.

And as work scales up on LNG Canadas $40 billion project, our province will benefit from an estimated 10,000 construction jobs and 950 permanent jobs. This new industry will create a legacy of skills and economic opportunity to sustain people and communities from the northeast to the north coast. Its clear that good things are happening in B.C.

In 2019, more than 45,000 jobs were added in the private sector, along with continued wage growth. In partnership with the BC Green Party caucus, the Emerging Economy Task Force will help keep B.C. at the cutting edge of clean tech, artificial intelligence and quantum computing. As Ive said before, we cannot have a strong economy without creating more opportunities for B.C.s rural regions to prosper.

Tourism has become a major province-wide employer and an economic driver for many small and rural communities. Growing the tourism industry can help boost local businesses and provide life-long careers for people right around our province.

New and upgraded infrastructure delivered through the Investing in Canada Infrastructure Program is also helping to build healthy and resilient communities.

Were working with the federal government, local governments and First Nations to deliver projects that support local growth, a green economy and inclusive communities. Projects are underway throughout the province with more on the way this year.

Originally posted here:
'A stronger B.C., for everyone': Read the full text of the B.C. Budget 2020 speech - CTV News

Read More...

On #WorldPangolinDay, we celebrate this roly-poly scaly anteater, one of the world’s most trafficked mammals – Massive Science

February 18th, 2020 5:55 pm

The 2019 novel coronavirus (2019-nCoV) outbreak has sparked a speedy response, with scientists, physicians, and front-line healthcare professionals analyzing data in real-time in order to share findings and call out misinformation. Today, The Lancet published two new peer-reviewed studies: one which found that the new coronavirus is genetically distinct from human SARS and MERS, related viruses which caused their own outbreaks, and a second which reports clinical observations of 99 individuals with 2019-nCoV.

The first cases of the coronavirus outbreak were reported in late December 2019. In this new study, Nanshan Chen and colleagues analyzed available clinical, demographic, and laboratory data for 99 confirmed coronavirus cases at the Wuhan Jinyintan Hospital between Jan 1 to Jan 20, 2020, with clinical outcomes followed until 25th January.

Chen and colleagues reported that the average age of the 99 individuals with 2019-nCoV is around 55.5 years, where 51 have additional chronic conditions, including cardiovascular and cerebrovascular (blood flow to the brain) diseases. Clinical features of the 2019-nCoV include a fever, cough, shortness of breath, headaches, and a sore throat. 17 individuals went on to develop acute respiratory distress syndrome, resulting in death by multiple organ failure in 11 individuals. However, it is important to note here that most of the 2019-nCoV cases were treated with antivirals (75 individuals), antibiotics (70) and oxygen therapy (75), with promising prognoses, where 31 individuals were discharged as of 25th January.

Based on this sample, the study suggests that the 2019 coronavirus is more likely to affect older men already living with chronic conditions but as this study only includes 99 individuals with confirmed cases, it may not present a complete picture of the outbreak. As of right now, there are over 6,000 confirmed coronavirus cases reported, where a total of 126 individuals have recovered, and 133 have died.

In a second Lancet study, Roujian Lu and their fellow colleagues carried out DNA sequencing on samples, obtained from either a throat swab or bronchoalveolar lavage fluids, from eight individuals who had visited the Huanan seafood market in Wuhan, China, and one individual who stayed in a hotel near the market. Upon sequencing the coronaviruss genome, the researchers carried out phylogenetic analysis to narrow down the viruss likely evolutionary origin, and homology modelling to explore the virus receptor-binding properties.

Lu and their fellow colleagues found that the 2019-nCoV genome sequences obtained from the nine patients were very similar (>99.98% similarity). Upon comparing the genome to other coronaviruses (like SARS), the researchers found that the 2019-nCoV is more closely related (~87% similarity) to two bat-derived SARS-like coronaviruses, but does not have as high genetic similarity to known human-infecting coronaviruses, including the SARS-CoV (~79%) orMiddle Eastern Respiratory Syndrome (MERS) CoV (~50%).

The study also found that the 2019-nCoV has a similar receptor-binding structure like that of SARS-CoV, though there are small differences in certain areas. This suggests that like the SARS-CoV, the 2019-nCoV may use the same receptor (called ACE2) to enter cells, though confirmation is still needed.

Finally, phylogenetic analysis found that the 2019-nCoV belongs to the Betacoronavirus family the same category that bat-derived coronaviruses fall into suggesting that bats may indeed be the 2019-nCoV reservoir. However, the researchers note that most bat species are hibernating in late December, and that no bats were being sold at the Huanan seafood market, suggesting that while bats may be the initial host, there may have been a secondary animal species which transmitted the 2019-nCoV between bats and humans.

Its clear that we can expect new findings from the research community in the coming days as scientists attempt to narrow down the source of the 2019-nCoV.

More here:
On #WorldPangolinDay, we celebrate this roly-poly scaly anteater, one of the world's most trafficked mammals - Massive Science

Read More...

MSU’s Beronda Montgomery recognized as one of the 100 most inspiring black scientists in America – MSUToday

February 18th, 2020 5:54 pm

Beronda Montgomery, MSU Foundation Professor, was listed as one of the 100 inspiring black scientists in America byCrossTalk, the official blog ofCell Press, a leading publisher of cutting-edge biomedical and physical science research and reviews.

It is an honor to be listed among other highly accomplished, established and emerging scientists who I admire and celebrate, said Montgomery.

Montgomery has also been aCollege of Natural Sciencefaculty member since 2004 who holds joint appointments in theDepartment of Biochemistry and Molecular Biologyand theDepartment of Microbiology and Molecular Genetics.

Based on my engagement with students, both undergraduate and graduate, and early-career professionals in venues such as annual conferences, professional development workshops, campus visits and online, representation matters greatly, Montgomery said.

The inaugural list was established to help solidify the legacy of 100 accomplished scientists from African, Afro-Caribbean, Afro-Latinx and African American backgrounds in the fields of life sciences, chemistry, engineering and physics.

CrossTalk contributor Antentor O. Hinton Jr., postdoctoral fellow at the University of Iowa, and two of his colleagues recognized a pressing need to increase the visibility of black scientists and took action to highlight 75 established investigators, including Montgomery, and 25 rising stars.

The scientists were chosen based on their position, teaching and mentorship history and roles as advocates for Diversity in STEM.

Hinton hopes that illuminating these scientists through social media will underscore the necessity for diversity in the academy and encourage the next generation of young, black scientists.

We are hoping to spread the word around the science community about how to teach, train and mentor minority scientists by showing them they are not the only ones in science that look like them, Hinton said. This type of list is something that is rarely captured or recognized.

Montgomery, who is also a member of theMSU-DOE Plant Research Laboratory, was chosen for her outstanding research, commitment to creating literature about diversity and inclusion and her dedication to mentoring and developing scientists of diverse backgrounds.

Individuals with shared demographics or backgrounds have shared poignantly how meaningful it is to engage and see individuals who are further along a career trajectory on highly visible platforms, Montgomery said. In this sense, the curators of this list are providing a highly visible platform for representation and potentially recognition.

Montgomerys exemplary career has been highlighted with several honors.

She was chosen for a National Science Foundation CAREER Award and was named a fellow of the American Academy of Microbiology for seminal contributions to understanding physiological and morphogenic adaptation of photosynthetic microbes to light.

For these and other outstanding contributions to the university, Montgomery became an MSU Foundation Professor in 2016.

CrossTalk plans to publish another list in 2021. For a full listing of this years 100 inspiring black scientists, please visitcrosstalk.cell.com.

More here:
MSU's Beronda Montgomery recognized as one of the 100 most inspiring black scientists in America - MSUToday

Read More...

How one smuggled elk could have caused an ecological crisis – The Register-Guard

February 18th, 2020 5:54 pm

Montana wildlife officials investigate unusual elk that they found was taken from Washington and set loose in Montana.

GREAT FALLS, Mont. It reads like a forensic crime drama and in a very real sense it is.

A Montana game warden learns of an unusual elk shot along the Rocky Mountain Front. The animal has physical peculiarities unlike anything the department has seen before. Genetic testing reveals that the young bull is of an exotic sub-species, and that it came from a herd more than 600 miles from where it was shot.

How did it get here? Who released it into the wild? What would have happened had the bull lived, intermingling for years with Montana's native elk population?

When a new disease appears in humans, pathologists make every effort to identify 'Patient Zero' the first person to become infected with the new pathogen. Finding patient zero is important because knowing that person's history can help to determine how and when the outbreak started.

This unusual 2-year-old elk harvested 16 months ago in the foothills of the Rocky Mountains is FWP's Elk Zero.

"It wasnt just an elk," remarked Dave Holland, game warden captain for Montana Fish, Wildlife and Parks, to the Great Falls Tribune. It had the ability to be an ecological disaster.

The elk with florescent antlers

On Oct. 20, 2018, a 'spike' bull elk was legally harvested north of Choteau. The hunter didn't immediately notice anything unusual about the animal, and took it to a wild game processor to have it butchered. It was there that things began to get interesting.

According to Holland, when the hunter returned to check on his order the processor asked him what the deal was with the elk's antlers. The bull's spikes had been painted orange, but the hunter hadn't noticed because he is color blind.

The elk's florescent antlers weren't its only unusual feature. When Warden Ron Duty inspected the animal's carcass he discovered it had been castrated. Duty began asking people around Choteau if they'd ever seen the elk, or knew who was responsible for it.

People had videos of this elk," Holland recalled. "It would walk right up to people. Obviously, humans had been interacting with this elk, probably since it was a calf."

Some of the locals had even given it a name "Buford" but no one claimed responsibility, nor claimed to know its origin.

The possibility that the elk had somehow escaped or been released from a regional game farm also was explored, but there was no record of a missing animal, something that would have almost surely existed had it been raised in commercial captivity.

Game farms are highly regulated," Holland noted. "They have to be fenced. All the animals have to be documented, and when they're harvested they have to be inspected.

FWP's interest in the case was motivated by more than simply idle curiosity about an unusual domesticated elk. Not knowing where Elk Zero came from, or whether it was just one member of a larger group of introduced elk, could have serious animal health implications.

The importation of any animal brings with it a full community of parasites and pathogens," explained Emily Almberg, disease ecologist for Montana Fish, Wildlife and Parks. Some things might be pretty benign, but there are things that we worry about that might be difficult to detect just by looking at an animal.

Chronic wasting disease, bovine tuberculosis and brucellosis are all diseases carried by elk, and which can be transmitted by them to other animals in some cases to livestock. Not knowing where Elk Zero had come from or what it had been exposed to was a serious consideration.

Yet, no one in the Choteau area seemed to know or would claim to know very much about it. There were, however, two individuals more directly connected to Elk Zero than the rest of the community.

FWP investigators were able to prove that two people from Choteau had been feeding the elk, which is a violation of state law.

In Montana it's a misdemeanor offense to attract wildlife of any type with food or other attractants like salt licks; the lone exception being the recreational feeding of birds. Violators face potential penalties of up to a $1,000 fine, six months in jail and a loss of their hunting, fishing, or trapping privileges.

Why feeding wildlife is a crime

Many Montanans feel a strong urge, born in compassion, to feed wild animals that appear to be struggling. Not only is feeding wildlife illegal, its also a bad idea.

People have the impression that wildlife need help; that we have to feed them to get them through the winter," said Game Warden Captain Dave Holland. "But when you put out an attractant like salt or food, you start unnaturally congregating the animals, which will help spread disease."

A recent example of this is the rapid spread of chronic wasting disease in deer congregating in and around Libby. The fatal neurological disease was unknown west of the continental divide until the spring of 2019, when a single white-tailed deer in Libby tested positive for the disease.

Since then more than 60 deer in the area have tested positive for CWD, many of them congregated in areas where people were actively feeding deer.

Feeding wildlife also habituates them to human food sources making it more likely they will be unable to survive on their own.

Youre actually doing them a disservice because if they dont learn how to forage for themselves theyre not going to survive after youve stopped feeding them," Holland notes. "It cant go on forever."

Most wildlife has evolved without humans helping them," he added. "Theyve got it figured out. They know how to survive. We don't find salt blocks in nature."

Holland said the residents were cited for feeding the elk, but repeatedly and adamantly denied having anything to do with his presence in Choteau, or to knowing who did.

"We are not saying they introduced the animal," Holland emphasized. We were able to prove they fed the animal, which is a violation of (Montana law.)

Potential impact of introduction

FWP officials were at a dead end, but there remained one possible avenue of investigation.

There was this rumor around the community that possibly this elk could have been brought to Montana from Washington," Holland said.

Holland contacted his counterpart with the Washington Department of Fish and Wildlife to see if was possible to connect Elk Zero with a herd in that state.

The possibility that Elk Zero was transported to the Choteau area from out of state added another layer of concern. Montana's elk herd belongs to a unique genetic subspecies identified as Rocky Mountain elk, which are prized by hunters for their large antlers. Those roaming the temperate forests of western Washington are Roosevelt elk, which have larger bodies, are slightly darker in color and have smaller antlers.

Despite the fact that Elk Zero had been castrated, the presence of a free-roaming bull elk, from a different subspecies and just reaching its sexual maturity, caused alarm among some wildlife managers.

If you start intertwining those populations (Roosevelt and Rocky Mountain) they lose the characteristics that made them distinct," Holland explained. "You run the risk of losing a distinct sub-species."

Almberg said its an open question whether the introduction of a single animal would make a meaningful genetic contribution, to the point where it would have any irreversible effects on the native herd. However, she does agree that cross-breeding between subspecies can result in a negative outcome for the species as a whole.

"If you mix distinct sub-species you have the potential of losing the genetics that control local adaptation," Almberg said. There is something called 'out breeding depression' where you see the decreased fitness of offspring when you cross those different subspecies, so lower reproductive output.

Finding the origin

Unlike Montana, Washington state has compiled a comprehensive genetic database of its elk herds. Wildlife geneticists there have identified 10 herds, which may intermingle at times, but maintain distinct genetic profiles.

However, submitting a single tissue sample from Elk Zero would not be enough to veritably identify it as a member of one of Washington's herds. Wildlife managers would need to obtain multiple samples collected from a variety of elk within the Choteau area to compare with the DNA profiles cataloged by Washington's Department of Fish and Wildlife.

During the remaining months of the 2018 hunting season and throughout the 2019 hunting season, FWP biologists and wardens collected 10 distinct tissue samples from elk harvested in the Choteau and Augusta areas. Along with a sample previously collected from Elk Zero, they were sent to Washington's molecular genetics laboratory in Olympia for DNA analysis.

"Using Washington state elk reference baselines, the unknown elk 1 (Elk Zero) genetically assigned to the Washington State Yakima elk herd with a positive probability of 99.98%," the lab results reported.

In other words, within a minute fraction of statistical probability, DNA testing had proven that the elk had been taken from a herd in southwest Washington; probably as a calf, and was transported to Montana where it was then released. FWP finally knew where Elk Zero had come from, but knowing that raised another concern.

Beginning in 2008, wildlife managers in Washington began receiving reports of elk with deformed, broken or missing hooves. The condition has now been identified as elk hoof disease, a bacterial infection that eventually cripples the animal, and which has now spread to parts of Oregon and Idaho.

"The disease appears to be highly infectious among elk, but there is no evidence that it affects humans," a report from the Washington Department of Fish and Wildlife states. "Currently there is no vaccine to prevent the disease, nor are there any proven options for treating it in the field."

Elk Zero tested negative for hoof disease, but keeping it out of Montana is a primary concern for herd managers.

"That lameness, the severe inflammation of hooves can cause ... a deterioration of body condition," Almberg said of the impacts of elk hoof disease. "They have a harder time moving around, they have a harder time feeding and keeping up with the herd. Those things can all contribute to lower survival."

"This hoof disease is a major issue impacting their elk herd," Holland added. We dont have it in Montana yet and we dont want it.

Who knows what the consequences would have been

At this point it appears that the illegal theft and release of Elk Zero had no impact on Montana's elk population, but that was solely due to dumb luck.

Holland acknowledges that whoever brought the animal to Montana probably didn't understand the ramifications of what they were doing, but the consequences could have been just as detrimental no matter the person's intentions.

With nearly 17 years of service as a game warden, Holland said he's never experienced anything quite like Elk Zero.

This is the first time Ive ever seen a large mammal moved from one state to another and released," he said. Ive been involved in removing fawns from houses where they were kept in the kids bedrooms, or theyre being raised as pets, but thats usually local people out walking locally and theyll bring an animal home. This is a whole different level. They literally went out and found an elk in Washington, put it in a trailer, drove it to Montana and let it go."

As an agency we move wildlife, but its highly regulated," Holland added. "Well spend years planning for and getting ready to move wildlife. If somebody just willy-nilly picks a calf elk up, throws it in a horse trailer and drives it to Montana theyre not thinking about hoof disease or CWD or the genetic aspects. Thats where this can become very dangerous to wildlife populations."

FWP District Supervisor, Gary Bertellotti, put the case of Elk Zero into the broader context of invasive species across the U.S. a problem becoming increasingly critical in Montana.

"Quagga mussels, CWD, feral pigs, lake trout we can see what the impacts are by looking at other things going on," Bertellotti said. "In all of those cases it was because somebody transported something. They all started with one person."

We dont know what that would be. Weve never had to deal with that," Bertellotti said of the implications, had Elk Zero been left fertile and undiscovered. Roosevelt elk may not be as compatible with the habitat and the weather systems we have here. If those genetics start to become more prevalent ... all of a sudden you could see that population not surviving as well as it should. It could have been anything from more susceptibility to diseases to the viability of the species. Who knows what the consequences would have been."

Closing the case

While a portion of the mystery surrounding Elk Zero has been solved, the investigation into who is responsible for taking the elk from Washington and releasing him in Montana is ongoing. Wardens in both states continue to ask questions.

What we really want to know is who brought it here," Holland said. We have a strong theory that it came from Enumclaw (a city roughly 30 miles east of Tacoma). We've developed the theory that it came from that area based upon information other than the genetics. We want contact with anybody with knowledge of how the animal arrived in Montana alive and who released it.

Just as with any crime drama, investigators hope someone will come forth with information regarding Elk Zero that will ultimately lead to an arrest.

Montana FWP maintains a confidential, toll-free hotline where people can report violations of fish, wildlife or park regulations. Since its establishment in 1985, TIP-MONT has received reports resulting in 1,521 convictions. To report a fish, wildlife or park violation call 1-800-TIP-MONT (1-800-847-6668). Callers can remain anonymous and may be eligible for a cash reward of up to $1,000. Nearly $155,000 in TIP-MONT rewards have been paid to citizens since the program was established.

I believe that there are people in Washington who have information about where this elk came from," Holland said. I believe theres people here in Montana who also know that. If they come forward with information that helps us find answers to this, then yes, absolutely theres going to be a TIP-MONT reward."

Read the original here:
How one smuggled elk could have caused an ecological crisis - The Register-Guard

Read More...

Study finds genetic link to extinct relative of humans in 4 modern West African populations – UCLA Newsroom

February 18th, 2020 5:54 pm

UCLA genomic research uses statistics rather than ancient DNA to look back more than 600,000 years

Leticia Ortiz/UCLA

The UCLA researchers studied four populations that mostly live in the area marked by the white band, in West Africa.

UCLA computational biologists have discovered that four populations in West Africa can trace about 8% of their genetic ancestry to an archaic hominin, an extinct relative of humans that branched off from the hominid evolutionary tree more than 600,000 years ago about 100,000 years earlier than Neanderthals did. The study is published in Science Advances.

Over the past decade, advances in computing, statistical analysis, molecular biology and genetics have revealed a richer picture of humans and their interactions with ancient relatives, such as Neanderthals. But research on the genetic ancestry of African populations has lagged behind discoveries about people with ancestral roots in Europe.

The researchers, from the UCLA Samueli School of Engineering, analyzed modern DNA obtained from an international repository of genomic data. In the past, researchers would have needed to compare the modern DNA to so-called reference DNA from ancient fossils to draw such conclusions. But the improved statistical techniques available today enabled them to look backward in time hundreds of thousands of years without fossil DNA.

This opens a new path in understanding the complexity of human evolutionary history in Africa, where the picture hasnt been as clear, said Sriram Sankararaman, the studys principal investigator, a UCLA assistant professor with appointments in computer science, human genetics and computational medicine.

The archaic hominin identified in the UCLA research is a close evolutionary relative of humans.

There is not a lot known about these archaic hominins, which makes finding out how this ghost population fits into human evolutionary history challenging. But our findings are very exciting, said Sankararaman, who also is a member of UCLAs Bioinformatics Interdepartmental Program.

Previous genomic studies have presented evidence that modern populations in Africa have complex genetic lineages, in which humans and close evolutionary relatives intermixed as recently as just a few thousand years ago. But this study may provide the strongest evidence yet that this intermixture took place.

The UCLA research reveals much more of that story for the four modern groups of people, the Yoruba of Nigeria, the Mende of Sierra Leone, the Esan of Nigeria and the Gambian in Western Divisions of Gambia.

We dont need reference DNA from fossils of the archaic hominin to confirm that, somewhere deep in our ancestry, humans intermixed with them, Sankararaman said. We can now see that such events took place by looking at our DNA itself.

Segments of Neanderthal DNA extracted from fossils have been found in most modern populations outside of Africa. DNA has also been extracted and analyzed from the more recently discovered Denisovans, another extinct group of archaic humans, whose DNA is found in people living today in South Asia and Oceania.

Archaeological evidence shows that modern and archaic humans coexisted in Africa, and some fossils have features that suggest mixing between the two populations. However, usable DNA has not yet been extracted from archaic human fossils that have been found in that region which is why the researchers ability to draw conclusions about evolution without reference DNA information could go such a long way toward solving previously unanswered questions.

Although the researchers found evidence of the archaic populations DNA in modern humans, the findings are not clear enough to determine whether these two distinct populations intermixed just once or several times over hundreds of thousands of years.

Sankararaman and Arun Durvasula, a UCLA graduate student studying human genetics, used two new statistical methods that look for patterns in the genome that could reveal the presence of DNA from a distantly related unknown archaic population. They looked at genomic data of 405 people from the1000 Genomes Project, an international public repository of genomic data from around the world. The results of both analyses were consistent.

The research was supported by the National Science Foundation, the National Institutes of Health, the Alfred P. Sloan Foundation and the Okawa Foundation.

Read more here:
Study finds genetic link to extinct relative of humans in 4 modern West African populations - UCLA Newsroom

Read More...

Estimating the Probability of Regulatory Registration Success – Regulatory Focus

February 18th, 2020 5:54 pm

This article discusses how to estimate the probability of regulatory/registration success for pharmaceutical products in development. The authors define the factors and methods used to assess regulatory/registration success and offer objective and data-driven methods to define probabilities for the purposes of documenting specific factors and/or risks relative to a likelihood of success. They provide a case study demonstrating how to use data and make estimate adjustments based on a variety of factors specific to individual programs. While this example applies to a drug and the US Food and Drug Administration (FDA), the same strategic approach can be applied to biologics, medical devices and combination products under review with any global regulatory Health Authority (HA).The article is based on a presentation by the authors at RAPS Regulatory Convergence in September 2019.IntroductionDetermining the Probability of Regulatory Success (PRS) for a product approval is a key driver for ensuring business/market readiness, including prioritization for the purposes of budgeting and resource planning. When considering PRS, a decision sciences approach focusing on facts is critical for avoiding biases. To do this consistently requires an ability to evaluate a program and create an objective PRS in a concise, well-documented, transparent manner along with objective, analytically driven decision-making. While a gut feeling about regulatory success may be based on experience and regulatory acumen, it cannot be objectively revised for changes in the regulatory environment and does not allow for a documented, well-vetted strategic and holistic analysis of the risks (downward adjustment) or strengths (upward adjustment) of regulatory considerations. Furthermore, gut-feeling does not support development of actionable mitigation strategies based on facts. Thus, this approach provides an objective framework for forming comparable assessments across a variety of projects.Technical vs. Regulatory SuccessIt is important to note that technical and regulatory success are different objectives and need to be assessed separately. Probability of Technical Success (PTS) applies to the probability a given clinical trial/study will be successful based on pre-defined endpoints, feasibility and other factors. Probability of Regulatory Success (PRS) is about whether FDA or another regulatory authority will grant approval for a product and based on factors within the scope of regulatory affairs, which often includes evaluation of the HAs perspective regarding the clinical relevance for a particular endpoint as it applies to suitability for defining efficacy in the context of an approval application for registration. The overall probability of success will need to consider both the PRS and the PTS and is calculated as PTRS = PRSxPTS.Six Elements of Good Decision MakingThere are six elements for good decision-making.Figure 1. Six Elements1

Read more:
Estimating the Probability of Regulatory Registration Success - Regulatory Focus

Read More...

Molecular Microbiology Market Global Production, Growth, Share, Demand and Applications Forecast to 2025 – Keep Reading

February 18th, 2020 5:54 pm

Global Molecular Microbiology Market 2019 by key players, regions, type, and application, forecast to 2025. Molecular Microbiology Market Report contains a forecast of 2019 and ending 2025 with a host of metrics like supply-demand ratio, Molecular Microbiology Market frequency, dominant players of Molecular Microbiology Market, driving factors, restraints, and challenges. The report also contains market revenue, sales, Molecular Microbiology production and manufacturing cost that could help you get a better view of the market. The report focuses on the key global Molecular Microbiology manufacturers, to define, describe and analyze the sales volume, value, market competition landscape, market share, SWOT analysis and development plans in future years.

Download Free Sample Copy of Molecular Microbiology Market Report: https://dataintelo.com/request-sample/?reportId=110545

The report provides information on trends and developments and focuses on market capacities, technologies, and the changing structure of the Molecular Microbiology Market . The new entrants in the Molecular Microbiology Market are finding it hard to compete with the international dealer based on quality and reliability.

Major Players included in this report are as follows RocheQiagenIlluminaAbbottHologicBioMerieuxDanaher (Cepheid)Myriad GeneticsDAAN GeneAgilentGenomic HealthBDFoundation Medicine

Molecular Microbiology Market can be segmented into Product Types as Quantitative PCR Detection Diagnostic KitsPathogenic Microorganisms Diagnostic Kits

Molecular Microbiology Market can be segmented into Applications as HumanVeterinary

Molecular Microbiology Market: Regional analysis includes: Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Buy the full version of this report at: https://dataintelo.com/checkout/?reportId=110545

Influence of the Molecular Microbiology Market report: Comprehensive assessment of all opportunities and risk in the Molecular Microbiology Market. The Molecular Microbiology Market recent innovations and major events. A detailed study of business strategies for growth of the Molecular Microbiology Market-leading players. Conclusive study about the growth plot of Molecular Microbiology Market for forthcoming years. In-depth understanding of Molecular Microbiology Market-particular drivers, constraints and major micro markets. Favourable impression inside vital technological and market latest trends striking the Molecular Microbiology Market.

Objective of Studies: 1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Molecular Microbiology Market. 2. To provide insights about factors affecting the market growth. To analyse the Molecular Microbiology Market based on various factors- price analysis, supply chain analysis, Porte five force analysis etc. 3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, Latin America and Rest of the World. 4. To provide country level analysis of the market with respect to the current market size and future prospective. 5. To provide country level analysis of the market for segment by application, product type and sub-segments. 6. To provide strategic profiling of key players in the market, comprehensively analysing their core competencies, and drawing a competitive landscape for the market. 7. To track and analyse competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Molecular Microbiology Market.

Customize Report and Inquiry for The Molecular Microbiology Market Report: https://dataintelo.com/enquiry-before-buying/?reportId=110545

The huge assortment of tables, graphs, diagrams, and charts obtained in this market research report generates a strong niche for an in-depth analysis of the ongoing trends in the Molecular Microbiology Market. Further, the report revises the market share held by the key players and forecast their development in the upcoming years. The report also looks at the latest developments and advancement among the key players in the market such as mergers, partnerships, and achievements.

In short, the Global Molecular Microbiology Market report offers a one-stop solution to all the key players covering various aspects of the industry like growth statistics, development history, industry share, Molecular Microbiology Market presence, potential buyers, consumption forecast, data sources, and beneficial conclusion.

About DataIntelo: DATAINTELO has set its benchmark in the market research industry by providing syndicated and customized research report to the clients. The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database contains various industry verticals that include: IT & Telecom, Food Beverage, Automotive, Healthcare, Chemicals and Energy, Consumer foods, Food and beverages, and many more. Each and every report goes through the proper research methodology, validated from the professionals and analysts to ensure the eminent quality reports.

Contact Info DataIntelo Name Alex Mathews Email [emailprotected] Website https://dataintelo.com Address 500 East E Street, Ontario, CA 91764, United States.

Read more:
Molecular Microbiology Market Global Production, Growth, Share, Demand and Applications Forecast to 2025 - Keep Reading

Read More...

Turkish doctor creates first see-through 3D maps of human kidney and eye – Daily Sabah

February 18th, 2020 5:54 pm

A Turkish doctor and his 15-member team have managed to render transparent 3D models of the human eye and kidney in what the scientific community heralds as an important development in organ production, the fight against cancer and even the mapping of the brain.

Genetics and neuroscience specialist Dr. Ali Ertrk, the director of the Institute for Tissue Engineering and Regenerative Medicine at Helmholtz Zentrum Mnchen and also principal investigator at the Institute for Stroke and Dementia Research at Ludwig Maximilian University's hospital, talked about their pioneering project in which they used microscopic imaging technology to reveal underlying complex structures of human organs by making them see-through. Their findings were published in the scientific journal Cell on Feb. 13.As part of the final stage of their project, Ertrk said they developed a new technology called SHANEL (Small-micelle-mediated HumAN organ Efficient clearing and Labeling) which is essentially a 3D laser microscope that can scan large tissues. Up until now, scientists had only managed to obtain cellular views of intact mouse organs in 3D. The chemicals used to turn mouse organs see-through did not work on human parts because of the accumulation of insoluble molecules including collagen over many years. After many trials, the team discovered CHAPS, a detergent that could seep into thick human organs and turn them transparent.

"We started these studies three years ago. In order to make 3D maps of these organs at a cellular level, we first had to make them visible under a laser microscope. Last year, we succeeded in making organs donated from cadavers transparent with various chemical solutions, as if turning milk into water," Demirren News Agency (DHA) quoted Ertrk as saying."We also developed an artificial intelligence algorithm that reduces the analysis of millions of images that we have obtained from the microscope, which would normally take humans centuries to analyze, down to just a few hours. Thus, for the first time in the world, we were able to make a 3D map of the human kidney and eye at the cellular level," he added.

The method could become a key technology for mapping intact human organs in the near future and hence "dramatically accelerate our understanding of organs such as the brain, their development and function in health and disease," explained Ertrk.

He said they believe that Shanel can help map the human brain at a molecular level and produce artificial human organs at a cellular level thanks to the 3D-bioprinting technology. Ertrk said they are currently working on mapping major organs such as the heart, kidney and pancreas.

"There is a huge shortage of organ donors for hundreds of thousands of people. The waiting time for patients and the transplantation costs are a real burden. Detailed knowledge about the cellular structure of human organs brings us an important step closer to creating functional organs artificially on demand," the biotech specialist said in a press release.

Read more from the original source:
Turkish doctor creates first see-through 3D maps of human kidney and eye - Daily Sabah

Read More...

Edited Transcript of VRT.AX earnings conference call or presentation 17-Feb-20 10:00pm GMT – Yahoo Finance

February 18th, 2020 5:53 pm

Half Year 2020 Virtus Health Ltd Earnings Call

Greenwich Feb 18, 2020 (Thomson StreetEvents) -- Edited Transcript of Virtus Health Ltd earnings conference call or presentation Monday, February 17, 2020 at 10:00:00pm GMT

TEXT version of Transcript

================================================================================

Corporate Participants

================================================================================

* Glenn Powers

Virtus Health Limited - CFO & Company Secretary

* Susan Channon

Virtus Health Limited - CEO, MD & Director

================================================================================

Conference Call Participants

================================================================================

* David Andrew Stanton

Jefferies LLC, Research Division - Equity Analyst

* Thomas Godfrey

UBS Investment Bank, Research Division - Analyst

================================================================================

Presentation

--------------------------------------------------------------------------------

Operator [1]

--------------------------------------------------------------------------------

Thank you for standing by, and welcome to the Virtus Health Limited Half Year FY '20 Results Conference Call. (Operator Instructions)

I would now like to turn the call over to Ms. Sue Channon, CEO. Please go ahead.

--------------------------------------------------------------------------------

Susan Channon, Virtus Health Limited - CEO, MD & Director [2]

--------------------------------------------------------------------------------

Thank you, and welcome to the Virtus Health FY '20 Half Year Results, and thank you for joining us. Virtus has demonstrated resilience and outperformed overall market volume growth in Australia. We have focused on improving profitability through cost reduction initiatives, which will be realized in future periods, and our investments in infrastructure in FY '19 have facilitated business development opportunities and growth. It's Virtus' diversified model, scale and geographical reach that provides an unrivaled platform for participation in all key fertility segments, both domestically and internationally, and it has delivered.

Story continues

Moving to Slide 4 and the financial results highlights. Virtus overall fresh cycle growth for the half year was up 1.3% with a total of 10,649 fresh cycles compared to 10,513 cycles in the prior corresponding period. Revenue was up 1% to $142 million on the prior corresponding period, and EBITDA was up 21.9% to $39.5 million, noting that $7.4 million of the increase was the result of adopting the new lease accounting standard.

Australian segment EBITDA increased 18.8% to $39.7 million. Again, $5.9 million of this increase was a result of the new standard. And International segment EBITDA increased 22.7%. Again, $1.5 million of this increase was from the adoption of the new lease standard.

NPAT attributable to ordinary equity holders was up 2.3% to $15 million with earnings per share up 2.4% to $0.1865. Headline earnings have been impacted by fair value gains on put options, lower interest costs and CEO transition and recruitment costs. The company has declared an interim dividend of $0.12 per share fully franked, unchanged from the prior year and payable on the 16th of April.

Turning now to Slide 5. Against the backdrop of a competitive business reproductive services market, we have responded accordingly and maintained our Australian market leadership position. We have adjusted our service model to the patient mix and changes in the market and continued the activities we started in FY '19 to remove cost in the business, which will deliver further benefits in future periods. As a result of our focus on patient care models, Virtus outperformed overall market growth in Australia, and cycle activity in the half increased 2.7% compared to an increase in Virtus available market of 1.2%. Notably, Australian IVF clinic EBITDA increased 4.5%, excluding the impact of the AASB 16 lease standard.

We have delivered strong growth in our Australian TFC low price clinics. And while our Victorian premium cycles were stable and Queensland grew, lower premium cycle volumes in New South Wales have impacted EBITDA, pathology revenue and IVF-related Day Hospital revenue in New South Wales. The investments made through FY '19 new Day Hospital facilities and our focus on business development are starting to deliver, with non-IVF Day Hospital procedure volume increasing 5.7%. International operations maintained EBITDA despite softer volumes, and we have seen EBITDA improvements in Ireland, Singapore and the U.K.

Management's focus on cost-out initiatives for margin improvement continued. However, overall corporate costs were impacted by CEO transition, recruitment and restructuring initiatives, which will deliver improved EBITDA margins in future periods.

Moving to Slide 6. And the Australian segment performance saw revenue up 0.3% to $112.8 million. And Australian segment EBITDA, including the impact of the new lease standard implementation of $6 million, increased to $39.7 million. The initiatives that we'll continue to deliver on this improved position are summarized on Slide 7.

So moving to Slide 7. In our summary at the end of FY '19, we noted that our focus in Australia will be on defending and building premium services, growing low price volumes, growing diagnostic revenue and growing non-IVF Day Hospital revenue.

Available market share increased to 40% in the first half compared to June 2019 closing position of 39.6%. Virtus cycle growth is 2.7% year-to-date compared to an available market growth of 1.2%. Virtus premium service remains our focus. And year-to-date, our premium cycle volume is up in 3 states of Queensland, Victoria and the ACT. Softer market conditions led to a reduction in our New South Wales and Tasmanian volumes. However, additional doctor recruitment is in progress in both states, in parallel with leadership changes guiding operational and cost-out initiatives.

Our TFC low price clinic saw volume growth of 30.2%, with low price cycles now representing 22% of overall volumes compared to 17.3% in the prior corresponding period. Overall, Australian Reproductive Services EBITDA margins have been impacted slightly and are down 0.5%, excluding the AASB 16 lease impact.

Diagnostic initiatives have not yet delivered with revenue flat as a result of lower pathology and PGT volumes, resulting in a less favorable revenue mix. Cost management initiatives have been implemented to align with volume softness, and there's a focus on increasing testing utilization within the new Revesby laboratory to drive internal and external referrals and utilization.

In our Day Hospital, non-IVF revenue growth of 6.8% has been achieved following business development initiatives in the 2 new Day Hospitals commissioned last year. Endoscopy procedures have been established in both facilities and are expected to deliver improved performance in the second half.

Moving to Slide #8 and the Australian ARS operations. Virtus Australia's overall cycle activity increased 2.7% in the first half to 8,302 cycles compared to an available Eastern Seaboard market volume increase of 1.2%, with a resulting EBITDA increase of $1.3 million. Virtus Victoria grew 10.2% on the prior corresponding period against a market growth of 1.7%. Premium cycle volume was stable with growth predominantly in low-cost services. Virtus Queensland grew 6.2% on the prior corresponding period against the market growth of 4.4%. Virtus New South Wales, including the ACT, declined by 3.4% on the prior period against the market decline of 0.5%. We had some movement of a few doctors due to retirement and international relocations that impacted this. And Virtus Tasmania declined by 20.3% on the prior period against a market decline of 5%, doctor resources again being the issue in Tasmania.

Virtus has continued to proactively target the low-cost segment with ongoing service model and pricing reviews and delivered a volume increase of 30.2% across the fertility center network with improved performance across all states. The TFC now represent 22% of Virtus Australia cycle volume against 17.3% in the prior period. And whilst we've experienced a small decrease in our EBITDA margins overall as a result of our targeted low price initiatives, EBITDA margins within our TFC to remain in excess of 35%.

Moving to Slide 9. Virtus Diagnostics revenue increased 0.2%, and EBITDA decreased 30.2% over the prior period as a result of less favorable revenue mix and cost. This was caused by continued softness in PGT utilization declining to 12.9% of fresh cycles from 14.6% in the prior corresponding period, impacting margin, and increased compliance costs as a result of the change in NPAAC supervision requirements. The first half FY '20 costs are recorded with a full half year impact compared to only 3 months in the prior period.

We will focus on further growth in Diagnostics by driving internal and external referrals to utilize increased capacity and expanded testing capability in the relocated laboratory supported by the additional scientific and pathologist resources; the introduction of new technologies for noninvasive PGT, which continues through the validation process and molecular genetics; and cost-out initiatives to align with volume.

Diagnostics continues to be an important part of our Virtus integration platform, and we are focused on growing the utilization of these investments made through FY '19 for an improved performance.

Moving to Slide 10 and the day -- Australian Day Hospital operations. The Day Hospitals experienced a difficult year in FY '19 as a result of the delays in commissioning the planned facility development. However, the first half FY '20 has seen an improvement in utilization and business development continues, delivering an increase of 6.8% on the prior corresponding period in non-IVF Day Hospital revenue across all Specialist Day Hospitals.

Overall Day Hospital EBITDA was flat as non-IVF growth was offset by lower IVF procedures impacted mainly by softer premium cycle volume in New South Wales. Business development has delivered a $300,000 EBITDA improvement over the prior period in Alexandria as more non-IVF surgery is secured. And whilst Hobart Specialist Day Hospital is still in early stage of business development, an operational restructure was completed in December 2019. And with the first endoscopy list commencing on the 13th of February, the outlook is more positive.

Moving to Slide 11. We have continued to diversify our revenue since listing through our international operations, which are now 21% of group revenues. We have made good progress through the half and have delivered earnings improvement in 3 territories: Ireland, Singapore and the U.K. International segment revenue is up 3.5% to $29.2 million, and segment EBITDA is $6.8 million.

And looking at the Irish operations on Slide 12. In Ireland, despite fresh cycle volume softness, we have seen EBITDA improvement of 17.1% on the prior period as a result of cost management initiatives. 1,075 cycles performed in the half compared to 1,094 in the prior period. Revenue was flat at EUR 10.5 million despite the lower fresh cycle volumes, which were offset by an increase in frozen cycles.

Moving to Slide 13. In our Danish operations, EBITDA overall was down on the prior period. 849 cycles performed in the half against 930 in the prior period. Revenue across the Danish clinics was down 7.5% at DKK 25.6 million. EBITDA, local currency, was down 45.9% on the prior period. Cycle volume was impacted by changes to Swedish donor regulations, reducing IVF tourism into Denmark. Short-term doctor resourcing issues impacting performance in Aagaard have now been addressed, and the clinic is fully resourced at December 2019. Management resources have been strengthened in Denmark to focus on business development and growth.

Moving to Slide 14. Complete Fertility has improved revenue and EBITDA performance this half from stronger donor activity and improved activity from the National Health Service. Complete Fertility performed 215 fresh cycles against 228 in the prior period, and revenue was up 13.4%. EBITDA was up 125% over the prior period driven by revenue initiatives and effective cost management.

And Singapore continued its positive performance with 208 cycles against 176 in the prior period. Revenue is up 13.5%, and EBITDA is up 77.4% on the prior period. The Singapore team has just celebrated their fifth year anniversary and continues to delight with consistently high patient survey results and the NPS score leading our group and benchmark for pregnancy and live birth success rates the highest across our network.

I'll now pass you over to Glenn Powers, CFO, to provide the detailed financial summary.

--------------------------------------------------------------------------------

Glenn Powers, Virtus Health Limited - CFO & Company Secretary [3]

--------------------------------------------------------------------------------

Thank you, Sue. Good morning, everybody, and turning to Page 17. So the statutory results, obviously, for Virtus, as with most companies, there is quite an influence of AASB 16, the new leasing standard. I think we just put it straight down to the bottom, the profit after income tax attributable to ordinary equity holders, that is up by 2.3% overall. The net AASB 16 impact on that was to reduce that NPAT number by approximately $200,000. Obviously, within the body of the P&L, you've got movements in terms of the segment EBITDA, the depreciation number and also the interest number. And those are noted at the bottom of the page, the actual numbers.

Looking at Slide 18, we just call out the net movement from noncash transactions, transaction expenses and also, this time, the CEO transition costs. And you can see there, there was a fair value adjustment related to the settlement of the final options in respect of Ireland and Tasmania. And I think the other cost movements are pretty much self-explanatory.

Slide 19, we do provide a detail of our AASB 16 adjustments. I don't propose to go through that in detail, but you can see there is that net decrease or that net impact to the actual profit after income tax of $0.02 million.

Turning to Slide 20. I think Sue has covered, obviously, a lot of the key drivers for the revenue and group EBITDA. I think a couple of key points to note. Firstly, Australian IVF clinic EBITDA increased by 4.5%. So we think that's a pretty positive result given the change in mix. So we have seen continued shift and increase towards more low price IVF. But the businesses have responded very well in terms of their operational management, and we have seen that 4.5% increase in our core clinic EBITDA.

We also saw EBITDA growth in Ireland. That was at 17%, so that was a very, very positive result there. And Singapore has continued to improve its EBITDA. U.K., which gave us a little bit of an issue last year, U.K., we've actually seen a recovery in performance and, again, a combination of good development of the business around our core IVF activity but also good cost management as well.

Two main headwinds, really, that we saw in the second -- in the first half with Diagnostics EBITDA and the impact of a shift in revenue mix away from the PGT activity. And also, as Sue said, we absorbed the full year -- a full half year of the compliance cost increase in this half. The other area was very much Denmark. Denmark, the doctor resource change in the Swedish donor market were both significant factors in the first half. But the businesses are very much set up now for the second half. We have doctors in place. We've added doctors in both clinic locations. So we do anticipate an improvement in performance in our Danish businesses in the second half.

I think we've covered the leasing position extensively. So again, although the movements don't look significant, in some ways, I think there are some positives around individual clinic performance and particularly our core Australian business.

Cash performance on Slide 21. We actually saw a very focal performance compared to the prior year comparison. And again, unfortunately, leasing does impact 2 or 3 numbers there: so the group EBITDA number, the lease interest number and also the lease principal payments number. They all flowed from the AASB 16 adjustments. But some of the core factors that actually show -- led to that improved cash performance, lower CapEx. Last year, fiscal year '19 was a big year in terms of capital expenditure. This year is more modest. And most of the CapEx this year continues to be around technology and laboratory enhancements, primarily EmbryoScope in 2 or 3 locations we've added the facility. We also saw improved working capital in this half, and that contributed to a turnaround of $9 million in free cash flow after dividends compared to the prior year.

Slide 22, the statement of financial position. Again, AASB 16, obviously, it impacts the net asset -- net financial position. So the net asset reduction includes a net impact of $8.7 million resulting from that new accounting standards, and that's covered in the first part of the slide. Dividend proposed, no change in this half year, so the dividend of $0.12 per share, fully franked, will be payable on the 16th of April. Sue?

--------------------------------------------------------------------------------

Susan Channon, Virtus Health Limited - CEO, MD & Director [4]

--------------------------------------------------------------------------------

Thanks, Glenn. So moving to Slide 23 and our summary. Fertility, as we have talked about previously, affects 1 in 6 couples' reproductive age worldwide, and the social and demographic factors that contribute to this global dynamic continues to drive demand for ARS. Our strategy has been to ensure that Virtus has the platform to self-sustain ongoing growth. And investments in people, technology and additional day hospital and diagnostic capacity support this strategy, the outcome of which is evident in our first half FY '20 results. As we continue to develop our approach and model to ensure we remain relevant to the patients we treat and the markets in which we operate, our network is well established in the all-patient demographics. Revenue growth will be achieved through a combination of service expansion and market penetration.

Our strategy is to focus on defending and building the premium ARS business, and we remain committed to growing our service and presence within the low price segment. Our day hospital strategy has seen a focus on attracting non-IVF surgical activity to our improved facility, and this is delivering. Our diagnostic throughput will be enhanced through our research into NIPT and business development activities to maximize internal and external diagnostic and genetic referrals. We have made good progress through the half across the international business and have addressed performance, resourcing and cost-out initiatives. And our international operations continue to contribute positively to the diversification of our revenue.

Our focus on margin improvement is ongoing with efficiencies and cost savings expected through recent management restructures and a greater emphasis on process improvements to ensure optimal patient care and experience. We have a very clear program of work to drive earnings growth through our cost-out initiatives, many of which have been completed in the first half. We are well positioned to deliver further earnings improvement across Virtus in the second half.

As you know, Kate Munnings will join Virtus on the 4th of May. Kate, most recently Chief Operating Officer with Ramsay Health Care Limited's Australian business, has a successful track record leading commercial improvement, organizational and business transformation across multiple sectors and industries. Kate's relevant experience, especially alongside specialist doctors, means she's well equipped to lead Virtus Health and the continued delivery of exceptional services to patients. I had the pleasure of having dinner with Kate last week, and I believe the organization is in good hands. I am confident she will continue to lead Virtus successfully into the next phase.

Glenn and I will be happy to take questions regarding Virtus Health results now.

================================================================================

Questions and Answers

--------------------------------------------------------------------------------

Operator [1]

--------------------------------------------------------------------------------

(Operator Instructions) Our first question is from David Stanton, Jefferies.

--------------------------------------------------------------------------------

David Andrew Stanton, Jefferies LLC, Research Division - Equity Analyst [2]

--------------------------------------------------------------------------------

First, I'd like to say a big thank you to Sue for all her help over the years. You'll be greatly missed. But my first question is, as an overall statement in Australia, can you give us an idea of why you think the premium market as you see it is declining?

--------------------------------------------------------------------------------

Glenn Powers, Virtus Health Limited - CFO & Company Secretary [3]

--------------------------------------------------------------------------------

Yes. I think the -- if we look at it -- well, the interesting thing is that it's not across -- it's not consistent across states. For example, we actually saw good growth in our Queensland premium service in the first 6 months. Victoria, we were stable in terms of the market. I think if you look at New South Wales, which is obviously the biggest market, the market was down generally in New South Wales. So of all the 3 big states, New South Wales was, by far, the weakest state in terms of market performance. So okay now, I don't think we feel necessarily that the premium is in decline. There's been a bit of talk overnight around fertility rates. And I think it is important just to note that the utilization rate of IVF continues to increase. And we've seen that again in the latest reports and comparing [ANZA] birth information compared to national birth numbers. So I think what we are just continuing to see is premium is possibly stable, but the growth in the sector does continue to be TFC/low price IVF. So -- and I think our record in the first 6 months shows that. Whether in New South Wales -- I think there may have been some local market conditions that have impacted the general state of the market in New South Wales, I think we'll see that over time in the next 6 to 9 months.

--------------------------------------------------------------------------------

Susan Channon, Virtus Health Limited - CEO, MD & Director [4]

--------------------------------------------------------------------------------

And David, sorry, as we've talked about previously, there will always be patients where the low-cost service is just not suitable. So the PGs, the genetics, et cetera, where patients will always need access to those higher-end services.

--------------------------------------------------------------------------------

David Andrew Stanton, Jefferies LLC, Research Division - Equity Analyst [5]

--------------------------------------------------------------------------------

Very good. Understood. And stop me if I'm wrong, regarding international, there were like 1 or 2 that weren't like this, but international cycles have decreased pretty much across the board. Is it -- would it be fair enough to say that that's due to the rest of the world playing catch-up on increasing the amount of frozen cycles or the fresh cycles, please, that we saw maybe 2 years ago in Australia?

--------------------------------------------------------------------------------

Glenn Powers, Virtus Health Limited - CFO & Company Secretary [6]

--------------------------------------------------------------------------------

Yes, we have seen a little bit of that. Certainly, in Ireland, we've seen that shift on more frozen cycles. So the business mix has changed a little bit. Again, if you look at the impact on our results then, our Irish business has improved EBITDA by 17% in the half. So it's sort of a bit of a natural evolution, it comes to a finite point. And we've seen that in the Australian sector. A couple of years ago, people were saying that it will be a one-for-one relationship between fresh and frozen, and that hasn't transpired. So yes, we've seen a little bit of transition as well in the Danish market. I think if you look at the Danish market, our volume decline, which is a good part of the decline in the international cycle, it has been more around doctor resource. So I think we feel we've got the doctor resource in place in both of our clinics now, and we'd like to think that we can see some business development activities, particularly in Denmark, in the next few months. And we'd like to think that we'll see our Danish business grow cycles in over the next 12 months.

Link:
Edited Transcript of VRT.AX earnings conference call or presentation 17-Feb-20 10:00pm GMT - Yahoo Finance

Read More...

Belarus, Egypt to sign intergovernmental program in education – Belarus News (BelTA)

February 18th, 2020 5:53 pm

MINSK, 17 February (BelTA) Belarus and Egypt are planning to sign an intergovernmental executive program in higher and postgraduate education, Ambassador Extraordinary and Plenipotentiary of Belarus to Egypt Sergei Terentiev said in an interview with BelTA.

The ambassador spoke about the Belarus-Egypt relations in education. Thus, the National Academy of Sciences of Belarus and the Academy of Scientific Research and Technology of Egypt signed a cooperation agreement to implement five joint research projects in crop farming, nanomaterials, molecular genetics and metallurgical science.

Belarus also invited Egypt to implement projects in e-government, digital transformation, computer games and training of IT personnel. Last year Belarus issued, for the first time, educational grants to citizens of Egypt for the bachelor and master's degree programs in Belarus.

The diplomat noted that some Belarusian universities signed agreements on cooperation with Egyptian colleagues. Belarusian National Technical University (BNTU) and Tabbin Institute for Metallurgical Studies are working to set up a joint engineering department.

Currently the parties are working to arrange a visit of the minister of higher education and scientific research of Egypt to Belarus in 2020.

Read more:
Belarus, Egypt to sign intergovernmental program in education - Belarus News (BelTA)

Read More...

The Chemical Imbalance Theory of Depression: Where Is It Going? – James Moore

February 18th, 2020 5:53 pm

The spurious chemical imbalance theory of depression is arguably the most destructive thing that psychiatry has ever done. Worldwide, millions of individuals are taking antidepressants, often with a cocktail of other drugs, because they have been told the blatant falsehood that they need the pills to combat a brain illnessa real illness just like diabetes.

Many of these individuals were told the additional lie that they needed to take the pills for life and are now addicted to the products.

At the present time, some psychiatrists and psychiatric facilities are backing away from the hoax. Most of these recantations take the form: We didnt mean it literally. The chemical imbalance thing was just a metaphor.

But what needs to be stressed is that the impetus for these diluted recantations came, not from psychiatry, but rather from the anti-psychiatry movement. It was the thousands of protesting voices that finally persuaded psychiatry that some backing off was needed, particularly as no proof of the theory had ever been uncovered.

The response from psychiatry, however, has not been commensurate with the damage done. What we need to see are full page ads in all major newspapers and cyber news outlets acknowledging that the chemical imbalance theory was a hoax; that it induced millions of people worldwide to take these drugs; and that it was developed and propagated to increase psychiatrys prestige and earnings. But thats not what we are seeing.

Instead, the general response from psychiatry continues to be one of denial, minimization, and excuse-making. The very eminent and learned Ronald Pies, MD, is the master of denial in this area, but minimizers and self-excusers abound. We are told that patients needed a simple formula for understanding their problems. They didnt. They needed the truth. We are told that patients needed a biological explanation to reduce stigma and alleviate their feelings of guilt. They didnt. They needed valid explanations. Besides, biological explanations actually increase stigma (here, here, here, and here).

The essential point is that as the drugs began to come on stream in the 50s, 60s and 70s, psychiatry needed illnessesreal illnesses with clear-cut biological etiologiesto cash in on the pharma-generated bonanza. Real illnesses were not to hand, so they invented their various chemical imbalance theories and promoted them as fact with all the vigor and energy that they could muster. Since then, psychiatrists have produced a truly overwhelming volume of research all aimed at proving the theory correct, but with no success. The simplistic shortage-of-serotonin-in-the-brain nonsense remains stubbornly unproven. As mentioned above, psychiatrists have backed off the more blatant expressions of this theory, but, remarkably, the treatments remain the same: Take these pills every day and come back in three months for more.

All of which is very interesting. But of even more interest is the recent development of a new approach to validatingor rather attempting to validatepsychiatric illness.

In JAMA Psychiatry, October 2019, Kenneth Kendler, MD, published an essay titled From Many to One to Many-the Search for Causes of Psychiatric Illness. Dr. Kendlers essential thesis is as follows. Prior to about 1850, causes of illness were anecdotally recorded from individual cases, resulting in long and diverse lists for all disorders. In the second half of the nineteenth century, single causes were found for many infectious diseases. Causal thinking shifted from multicausal approaches to monocausal theories of etiology. Dr. Kendler writes, Indeed proving monocausal etiology became a way to establish the legitimacy of a disorder. In the mid 20th century, general medicine shifted to a chronic disease model in which paradigmatic disorders, such as cancer and cardiovascular disease, were shown to be highly multicausal. Psychiatry, however, continued to pursue monocausal theories in their attempt to legitimize their activity. Despite ample evidence to the contrary, monocausal thinking continues to influence our field, for example, in the popular but improbable view that we can, with a few key advances, move easily from descriptive to etiologically based diagnoses.

Dr. Kendler works for Virginia Commonwealth University. He is a Distinguished Professor of Psychiatry, Professor of Human Genetics, and Director of the Virginia Institute of Psychiatric and Behavioral Genetics. He served on the DSM-III-R Work Group, on the DSM-IV Task Force, and on the DSM-5 Work Group for mood disorders.

Dr. Kendlers essay highlights two main themes: firstly, that psychiatry is not blameworthy in the promotion of spurious and monocausal etiologies; and secondly, that even though the quest has failed dismally, this is not a problem because a multicausal approach is better anyway.

Here are some pertinent quotes from Dr. Kendlers paper, interspersed with my thoughts and observations.

The second epidemiologic phase, termed infectious disease, had as its paradigm the germ theory, lasted roughly from 1850 to 1950, and was dominated by monocausal etiologic theories in which the relationship between putative etiologic agents and specific diseases was one to one (although most investigators recognized such modifying factors as host resistance). The third epidemiological phase, termed chronic disease, had a dominant black box paradigm. It incorporated a multifactorial disease model for what was termed chronic noncommunicable diseases (eg, diabetes, heart disease, certain forms of cancer, and hypertension), diseases often associated with particular lifestyles that could not be explained by a single salient causal factor. In this paradigm, the goal of epidemiology was to determine the magnitude and causal nature of the associations between a wide range of putative risk factors and these chronic noncommunicable diseases. This phase began around 1950 and has lasted until current times. (p 1087)

The essential point that Dr. Kendler is making here is that there is a fundamental distinction between these two phases. But is this really so? Let us compare scarlet fever, a classic monocausal infectious disease, with diabetes, which is the first example Dr. Kendler gives of a multicausal chronic disease.

Scarlet fever is caused by a streptococcal infection of the throat, while diabetes is widely considered to arise from many causes, or risk factors, as they are sometimes called. These include inheritance, lifestyle factors, and diet. However, the essential cause of diabetes is an inability of the pancreas to produce enough insulin to adequately process and utilize the sugar in the blood stream. This in turn stems from a damaged or compromised pancreas, ingestion of more sugar than the pancreas can cope with, or other causes. When considered in this light, diabetes is a monocausal illness, even though there are multiple pathways to the final cause.

Applying the same logic in reverse, one can make a case that scarlet fever is multicausal. Firstly, the individuals throat has to be exposed to the streptococcal infection. Secondly, the germ has to survive the initial immune system response. Thirdly, as hand-washing is one of the major protections against contracting this illness, anything that militates against frequent hand-washing could be considered a cause, e.g., living in crowded unsanitary conditions.

In addition, the time period leading up to the contraction of an illness can be analyzed and re-analyzed almost indefinitely. Any incident or event in that time frame has the potential to be considered a contributing cause. Let us say, for instance, that a child contracted scarlet fever at a birthday party given by one of his friends. We could legitimately say that the invitation caused the illness; or that the childs acceptance of the invitation was the cause. Or let us become even more imaginative and say that the child in question was rather shy and didnt want to go to the party, but was prevailed upon by his parents to do so, in the belief that it would do him good. So the illness was caused inadvertently by the parents! And so on.

Back to Dr. Kendlers essay.

During the second half of the 20th century, the approach to disease causation of major parts of psychiatry was out of step with the rest of medicine and medical epidemiology. Instead of multicausal models, the rising and soon to be dominant field of biological psychiatry pursued monocausal models for their major disorders. (p 1088)

The reader will have no difficulty seeing where this is going. Psychiatrists were chasing single causes, for their so-called illnesses, when they should have been looking for many causes. So the great failure of psychiatry to deliver the promised causes wasnt a failure at all. They were simply looking for the wrong kind of explanation. Butand this is the point that Dr. Kendler glosses overit wasnt a benign error. Psychiatry needed clear-cut biological explanations in order to take advantage of the drugs and to establish themselves as bona fide doctors. In this regard they routinely prioritized their own guild interests over the welfare of their clients.

In the early to mid-1960s, through histofluorescence stains, the cell bodies and neuronal pathways of the 3 monoamine neurotransmitters were identified: dopamine, norepinephrine, and serotonin. This further spurred the development of 3 long-lived monocausal neurochemical theories for psychiatric illness. All were proposed in the mid-to-late 1960s: the catecholamine hypothesis of affective disorders, the dopamine hypothesis of schizophrenia, and the serotonin hypothesis of depression. Although based on a range of evidence, the primary support for these theories was reasoning backward from therapeutic mechanisms to etiology. That is, for Parkinson disease the logic was sound: clarification of cause leading to a proposed treatment. By contrast, psychiatry followed the more problematic approach of extrapolating backward from a proposed mechanism of treatment to the cause of the disease. Although the original articles proposing these theories were couched in qualifications, as a psychiatry resident in the late 1970s, I was taught these theories as monocausal explanations. Schizophrenia was caused by excess dopamine transmission. Decades later, I would commonly see patients who would say some version of my psychiatrist said I have a chemical imbalance in my brain and then proceed to summarize one or more of these theories. It is now widely accepted that these theories, claiming a dominant causal pathway to illness, are false although debate continues regarding the dopamine hypothesis. (p 1088) [Emphases added]

Theres a lot in this quote. Firstly, note the phrase Although based on a range of evidence. In fact the evidence supporting these chemical imbalance theories was flawed, i.e. it was not evidence at all. Secondly, note the sentence By contrast, psychiatry followed the more problematic approach of extrapolating backward from a proposed mechanism of treatment to the cause of the disease. [Emphasis added] This was not a more problematic approach; it was a bogus approach; a hoax. And if the psychiatrists who promoted these theories couldnt see the deception, then they had no business presenting themselves as a helping profession. It becameand perhaps still isroutine for mental health workers who drew attention in case conferences to critical psychosocial realities to be told by the psychiatrists that first we have to treat the depression, which invariably meant drugs or electric shocks.

Although the original articles proposing these theories were couched in qualifications, as a psychiatry resident in the late 1970s, I was taught these theories as monocausal explanations. (p 1088)

Dr. Kendler did his psychiatry residence at Yale University, during which, he tells us, he was taught the various chemical imbalance theories, presumably as valid, factual explanations. This seems straightforward enough, and presents no surprises. But there is some ambiguity. If I were to say that my father taught me how to ride a bike, I am actually making two statements. Firstly, I am asserting that my father expended some time and effort in this process, and secondly, that his efforts were successful. In his essay, however, Dr. Kendler leaves this issue vague. Did he believe the hoax, and did he in turn foist it on his customers? It is obvious that Dr. Kendler is a very bright person and, given the fact that the original articles proposing these theories were couched in qualifications, it is reasonable to believe that he did see through the whole sordid deception. So what did he say to the trusting victims who parroted back the bogus theories to him? Did he tell them the truth? Or did he play along?

It is not my intention to pressure Dr. Kendler on this matter. Economics can make cowards of us all. But if he genuinely wants to promote honesty and integrity in this area, it would be helpful if he were to write an expos of sorts concerning the pressures he experienced in these matters during his psychiatric residency at Yale. Such an endeavor would be unlikely to endear him to his colleagues, but would shed light on a facet of psychiatry that has for too long been kept hidden, and might even encourage other psychiatrists to follow suit.

Psychiatry has had a long-term love affair with monocausal theories of illness dating at least from the late 19th century, heavily influenced by our success at the identification and effective eradication of GPI [general paresis of the insane]. In the latter half of the 20th century, with both neurochemical and molecular genetic theories of illness, our enthusiasm for monocausal theories outran our common sense. Emerging from decades of psychoanalytic dominance, we were deeply committed to reestablishing our medical legitimacy. What better way to show that we treated real diseases than to show that they were monocausal? (p 1089)

There is a distinct exculpatory tone to this passage. Instead of acknowledging that psychiatrists were systematically deceiving their customers for their own benefit, Dr. Kendler tells us that it was just a long-term love affair, in which their enthusiasm for monocausal theories outran [their] common sense.

Indeed, as mentioned earlier, this exculpatory stance is one of the dominant themes of the essay. Here are some additional quotes:

Our long yearning for monocausal theories of etiology drives, at least in part, our heartfelt calls for the abandonment of our descriptive nosologic systems in favor of an etiologic model. (p 1089)

There have not been heartfelt calls or long yearning from psychiatry on this matter. Rather, they simply declared the matter resolved, and promoted the chemical imbalance theories as fact. I have written extensively on this subject here.

This search has 2 prominent phases, both fueled by new scientific developments. The first was neurochemical. The stage was set in 1957 by Montagus discovery of dopamine in brain tissue quickly followed, in 1960, by the dramatic finds from Ehringer and Hornykiewicz of the decreased content of dopamine in the postmortem brains of patients with Parkinson disease. Here was a major neurologic disorder fitting apparently into a monocausal neurochemical theory. What could be more exciting for the then young and ambitious field of biological psychiatry? (p 1088) [Emphasis added]

So the systematic, self-serving, and widespread deception perpetrated by psychiatry stemmed from their excitement! How eminently understandable.

The second wave of monocausal theories in psychiatry was genetic. Despite much evidence from family studies that major psychiatric disorders did not segregate in pedigrees as expected for a mendelian condition, the first successful linkage study of Huntington disease in 1983elicited intense excitement in psychiatric genetics and launched a large number of linkage studies, especially of schizophrenia and bipolar illness. (p 1088) [Emphasis added]

Even more excitement!

Yet the ghost of GPIof monocausal psychiatric disorderslurks in our memory. To this day, it influences our nosologic thinking. It makes us too willing to adopt a monocausal perspective in our clinical work and in our explanations of psychiatric disorders to patients. Monocausal thinking continues to support hard reductionist approaches that seek the cause of our major disorders and is one of several factors inhibiting collaborative psychiatric research work across scientific levels. (pp 1089-1090)

So it is the ghost of GPI lurking in psychiatrists collective memories that inhibits them from acknowledging the non-medical nature of depression, painful memories, paranoid thinking, distractibility, etc

Despite the wide acceptance of the chronic noncommunicable disease model in modern medicine, there remains in our culture a sense that disorders with many causes have reduced legitimacy. Therefore, both clinicians and their patients would feel more secure if a large indisputable cause were found for their disorders. This, however, is a social and not a scientific problem. (p 1089-1090) [Emphasis added]

So a monocausal breakthrough would make clinicians and their patients feel more secure. So, telling a bereaved woman that her sadness is the expected and reasonable response to the death of her spouse will make her feel less secure than telling her the gross falsehood that there is something wrong with her brain. Or telling a battered wife that her sadness is the understandable response to the violence would make her feel less secure than telling her it stems from a brain disease. This is exculpation taken to a new level. We lie to our customers because it makes them feel more secure.

Dr. Kendler closes his essay on an upbeat, exhortative note.

The stigma of psychiatric illness and the low status of the psychiatric profession need to be addressed at both social and political levels and will not likely be solved through the discovery of major single causes for our illnesses. The legitimacy of the discipline of psychiatry does not rest on our ability to find single major causes of our disorders. (p 1090)

How does one address the stigma associated with psychiatric disorders and the low status of the psychiatric profession at social and political levels? PR campaigns? Lobbying politicians to pass psychiatry-friendly laws? These things are happening already, but the routine prescribing of pills and electric shocks continues to be psychiatrys only stock in trade, and the self-centered promotion of biological psychiatry continues to dominate the field.

Rather than grieving for the loss of our visions of another GPI around the corner, we can positively embrace the etiologic complexity of our disorders. (p 1090)

Actually they are not psychiatrists disorders. Rather, they are the disorders that psychiatrists self-servingly foist on their hapless clients.

If the common, morbid dysfunctions of the human cardiovascular, immune,hormonal, musculoskeletal, and gastrointestinal systems, which cause most of the morbidity in our country, are highly multifactorial, could we realistically expect anything else from the parallel dysfunctions of our mind/brain system? (p 1090)

In other words, psychiatric illnesses have as much ontological reality as diabetes, heart disease, cancers, hypertension, etc. Dr. Kendler encourages his colleagues not to grieve the abandonment of the quest, but rather to positively embrace the etiological complexity of psychiatric illnesses.

But what does etiologic complexity actually mean in this context, and why is it so important to Dr. Kendler?

Dr. Kendler uses various terms to describe etiologic complexity. For instance, he describes the illnesses in question as multifactorial, chronic noncommunicable, often associated with particular life styles, multicausal, etc.

Dr. Kendler has been working on this general theme for quite some time. In 2012 he published an article in Molecular Psychiatry calledLevels of explanation in psychiatric and substance use disorders: implications for the development of an etiologically based nosology (2012: 17, 11-21). Here are two quotes from the abstract:

The soft medical model for psychiatric illness, which was operationalized in DSM-III, defines psychiatric disorders as syndromes with shared symptoms, signs, course of illness and response to treatment. Many in our field want to move to a hard medical model based on etiological mechanisms. (p 11)

a move toward an etiologically based diagnostic system cannot assume that one level of explanation will stand out as the obvious candidate on which to base the nosology. This leaves two options. Either a hard medical model will be implemented that will require a consensus about a preferred level of explanation which must reflect value judgments as well as science. To take this approach, we need to agree on what we most want from our explanations. Alternatively, we will need to move away from the traditional hard medical model that requires that we ground our diagnoses in single biological essences, and focus instead on fuzzy, cross-level mechanisms, which may more realistically capture the true nature of psychiatric disorders. (p 11)

Theres a lot here. Firstly, there is what many readers might consider a contradiction in the first sentence: The soft medical model for psychiatric illness, which was operationalized in DSM-III, defines psychiatric disorders as syndromes [Emphases added] But syndromes are not illnesses. Heres how DSM-III defines a syndrome:

A grouping of symptoms that occur together and that constitute a recognizable condition. The term syndrome is less specific than disorder or disease. The term disease generally implies a specific etiology or pathophysiological process. In DSM-III most of the disorders are, in fact, syndromes. (p 368)

And elsewhere in the text (p 6), the term mental disorders is defined as a clinically significant behavioral or psychological syndrome. However, even before DSM-III was published (in 1980), it was widely accepted and promoted by psychiatrists that many psychiatric disorders, including depression, were genuine bona fide illnesses. (In my entire career I have encountered only one psychiatrist who acknowledged that psychiatric disorders were syndromes, not real illnesses.) This massive deception has been discussed at great length in various venues and need not be labored here. But what is noteworthy is Dr. Kendlers next sentence: Many in our field want to move to a hard medical model based on etiological mechanisms. But in fact almost all psychiatrists have already made this move and have been promoting the chemical imbalance hoax for decades. Many psychiatrists who are now retired practiced nothing but bio-bio-bio psychiatry for their entire careers.

Obviously Dr. Kendler is aware of this. So, what point is he making?

a move toward an etiologically based diagnostic system cannot assume that one level of explanation will stand out as the obvious candidate on which to base the nosology. (p 11)

In other words: if psychiatrists continue down their present road trying to use science to prove their various disease theories, they are just as likely to discover that major depression, schizophrenia, PTSD, etc., stem from psychosocial and economic causes rather than from their cherished brain diseases. In effect Dr. Kendler is saying: abandon the search or we run the risk of losing everything. (We) cannot assume that one level of explanation will stand out as the obvious candidate on which to base the nosology. In other words, we cannot assume that biological explanations will emerge as the dominant perspective. Dr. Kendler warns his colleagues, we need to agree on what we most want from our explanations. What does he mean by this? Read on.

Here are some quotes from the body of the 2012 article:

Let me sketch what we might find for MD [major depression]. Single gene effects for MD are even smaller and less well established than for AD [alcohol dependence]. Aggregate genetic effects are also somewhat weaker and are modified by a range of environmental exposures. Structural and functional magnetic resonance imaging studies have suggested a range of central nervous system abnormalities that correlate with MD but the specificity and strength of these associations, as well as their causal status, remain uncertain. A number of physiological abnormalities including endocrine and immune function have been reported in cases of MD but again, sensitivity and specificity have typically remained modest. Several aspects of personality are strongly correlated with risk for MDespecially neuroticism. This association is almost certainly causal but is nonspecific as high levels of neuroticism predispose to many internalizing disorders. Some cognitive processes may be more specific and here their causal role has been clearly demonstrated by many randomized controlled trials of cognitive behavior therapy. A range of early environmental risk factors have been well established for MD (for example, poor parenting and sexual abuse) and are generalizable across cultures but are quite nonspecific. Stressful life events can be quite strongly associated with risk for MD. Much, but not all, of this association is likely causal and some classes of events are moderately specific for MD. However, stressful life events are likely to be quite distal influences on risk pathways to MD and many such events predispose to other psychiatric disorders. Economic factors can impact on risk for MD via levels of unemployment and cultural factors can shape the expression and help-seeking behavior of those with depressive syndromes. (p 16)

Nature does not appear to have provided us one critical level of explanation for psychiatric illness that stands out from the background. For CF [cystic fibrosis], explanatory power is highly concentrated in the level of DNA base-pair variation. For psychiatric disorders, explanatory power is dispersed and diffuse. (p 16)

So, genuine scientific investigation might show that depression, say, is as likely to stem from sad events in peoples lives as from any kind of brain disease.

The current status of our science, and, most probably, the nature of psychiatric disorders themselves, does not yield up unambiguous choices for the best level at which to define psychiatric illness etiologically. (p 16) [Emphasis added]

Or might even show that depression is much more likely to stem from sad events.

But, despite these obvious concessions to a bio-psycho-social-cultural-economic perspective, Dr. Kendler is careful not to jettison the baby with the bathwater. He still seeks to preserve the notion that psychiatric disorders are real illnesses.

a rejection of the hard medical model for psychiatric disorders should not be misunderstood as setting up a deep divide between etiologic models for psychiatric and medical disorders. (p 16)

If, as our review of the data suggest, there is no a priori way to pick a single level of explanation on which to base an etiological nosology, we could try to argue it out on pragmatic grounds. What do we most want as a field from our explanations? (p 17)

What indeed? To date, psychiatrys primary motivations have been enhanced prestige, expansion of scope, and increased earning power, all of which were well-served by the chemical imbalance hoax.

What Dr. Kendler is telling his colleagues here is that the hoax is exposed; that science will not give them what they seek; and that by continuing to promote a purely biological perspective they are running the risk of losing what they want most: the reality of psychiatric illness. In other words, the science is not going our way, so we need to ask ourselves what do we most want, and then promote concepts that will help us achieve this. Dr. Kendlers wording is carefully chosen, but it seems to be that he is encouraging his colleagues to dispense with the formalities and neutrality of science and promote concepts that will retain psychiatrys hegemony in the field: what we want most.

Towards the end of the article Dr. Kendler provides us with more descriptors of the psychiatric diagnostic system that he envisions for the future. These include disorders (of) complex, mutually reinforcing networks of causal mechanisms, disordered multi-level mechanisms, and higher-order disturbances in multi-level mechanisms. [Emphases added]

Note the words disorders, disordered, and disturbances. Dr. Kendler, as in the 2019 paper, affords no recognition to the fact that the thoughts, feelings, and actions in question are not actually illnesses, and in many (perhaps most) cases are clearly adaptive.

Four years later (2016) Dr. Kendler published The Nature of Psychiatric Disorders (World Psychiatry, 2016: 15: 5-12). Heres a quote from the abstract:

Therefore, we should argue more confidently for the reality of broader constructs of psychiatric illness rather than our current diagnostic categories, which remain tentative. Finally, instead of thinking that our disorders are true because they correspond to clear entities in the world, we should consider a coherence theory of truth by which disorders become more true when they fit better into what else we know about the world. In our ongoing project to study and justify the nature of psychiatric disorders, we ought to be broadly pragmatic but not lose sight of an underlying commitment, despite the associated difficulties, to the reality of psychiatric illness. (p 5)

Note the phrase we ought to not lose sight of an underlying commitment, despite the associated difficulties, to the reality of psychiatric illness. To which I can only ask: why not? The common and accepted meaning of the word illness is something going significantly awry with the structure or function of an organ. If what psychiatrists call major depression doesnt actually conform to this description, why should psychiatry maintain an underlying commitment to the reality of psychiatric illness? Also, note the phrase In our ongoing project to study and justify the nature of psychiatric disorders [Emphasis added]. Isnt this arguably the very opposite of valid science? Didnt most of the great errors of science stem from efforts to justify the status quo often for the benefit of various powerful conflicting interests?

Despite Dr. Kendlers writings on these matters, his polycausal model is not attracting a large following. Here are quotes from the websites of some psychiatric facilities:

Harvard Medical School: What causes depression?

Certain areas of the brain help regulate mood. Researchers believe that more important than levels of specific brain chemicals nerve cell connections, nerve cell growth, and the functioning of nerve circuits have a major impact on depression. Still, their understanding of the neurological underpinnings of mood is incomplete. [Note how the simplistic chemical imbalance theory is being nudged aside, and being replaced by the more generic notion of nerve functioning.]

This quote is followed by five pages of closely-written type under the following headings: (Brain) regions that affect mood; Areas of the brain affected by depression (with picture); Nerve cell communication; How the (neurological) system works; When the (neurological) system falters; Kinds of neurotransmitters; How neurons communicate (with picture); Genes effect on mood and depression; Temperament shapes behavior; Stressful life events; How stress affects the body; Early losses and trauma; Seasonal affective disorder; Medical problems; and Depression medications.

The material is heavily slanted towards a biological perspective. Even the headings that sound psychosocial are slanted. The section on stressful life events contains:

Disturbances in hormonal systems, therefore, may well affect neurotransmitters, and vice versa.

The section on early losses and trauma contains:

Many researchers believe that early trauma causes subtle changes in brain function that account for symptoms of depression and anxiety. The key brain regions involved in the stress response may be altered at the chemical or cellular level.

Mayo Clinics article Depression (major depressive disorder) under the section Causes:

Its not known exactly what causes depression. As with many mental disorders, a variety of factors may be involved, such as:

Biological differences.People with depression appear to have physical changes in their brains. The significance of these changes is still uncertain, but may eventually help pinpoint causes.

Brain chemistry.Neurotransmitters are naturally occurring brain chemicals that likely play a role in depression. Recent research indicates that changes in the function and effect of these neurotransmitters and how they interact with neurocircuits involved in maintaining mood stability may play a significant role in depression and its treatment.

Hormones.Changes in the bodys balance of hormones may be involved in causing or triggering depression. Hormone changes can result with pregnancy and during the weeks or months after delivery (postpartum) and from thyroid problems, menopause or a number of other conditions.

Inherited traits.Depression is more common in people whose blood relatives also have this condition. Researchers are trying to find genes that may be involved in causing depression.

University of Rochester Medical Center, Major Depression, under the heading What causes depression?

Researchers are studying the causes of depression. Several factors seem to play a role. It may be caused by chemical changes in the brain. It also tends to run in families. Depression can be triggered by life events or certain illnesses. It can also develop without a clear trigger.

And so on. Its clear that most pro-psychiatry writers have received the message to downplay the simplistic too-little-serotonin-in-the-brain theory. Many, however, are still relying on this notion but couching it in different terms or adding some token psychosocial material, usually referred to as triggers.

In psychiatry there is no actual illness behind the symptoms. Major depressive disorder and psychiatrys other functional disorders are nothing more than loose collections of vaguely and arbitrarily defined thoughts, feelings, and behaviors. Psychiatrys clear objective in the past fifty years has been to pathologize every significant difficulty of thinking, feeling, and/or behaving, and to sell these bogus illnesses to the general public, the media, insurance companies, and government officials. The only essential difference between psychiatrists and street-corner drug-pushers is that the latter dont pretend that they are treating or curing illnesses.

Dr. Kendler has written an interesting and thought-provoking essay, but, in my view, has missed the central point: that depression, regardless of severity, duration, or impact, is not an illness. In fact, the opposite is the case. Depression is an adaptive mechanism that encourages us to make changes in our lives, habits, or circumstances. Just as pain provides an incentive to remove our hand from a hot stove, so depression encourages us to leave home, change jobs, develop some assertion skills, find a partner, etc. It is a mechanism that we share with virtually all other animal species, though the precise nature, complexity, and impact of the depression varies enormously.

As a species we can experience a wide range of emotions. We have this ability because we have machinery in our brains, and other organs, that enables this to happen. It is widely believed in psychiatric circles that if neurobiologists could uncover the precise mechanisms involved in experiencing depression, this would prove that depression is an illness. But, in fact, uncovering such mechanisms would no more pathologize depression than the neurobiology of walking or seeing or writing poetry would pathologize these activities. All human activity has a neurobiological underpinning, without which the activity cannot occur. We cannot see without eyes and optic nerves, etc.; we cannot feel without feeling machinery though we dont know exactly what this machinery is or how it works.

It certainly needs to be acknowledged that a persons feeling apparatus can malfunction, but such malfunctions are almost certainly rare, and cannot be routinely inferred from the presence of depression, regardless of severity. I have personally worked with hundreds of depressed individuals in my career, but have never encountered anyone whose level of depression was incommensurate with his/her story. Psychiatrists have essentially numbed themselves to this reality, firstly because of their spurious atheoretical approach (if youve got the symptomsregardless of why youve got themthen you have the illness); and secondly because their primary, or perhaps only, agenda is to clinch the diagnosis. It is particularly interesting in this regard that before the arrival of the pills, psychiatrists, most of whom practiced some kind of psychotherapy, had no difficulty recognizing the reality: that if people are given the opportunity to talk, they can tell you very clearly why they are depressed.

For several decades psychiatry has been lying to its customers that depression is a pathological state caused by a shortage of serotonin, and can, apparently miraculously, be diagnosed without ever examining the brain but simply by scoring yes on five of the nine items on the facile checklist. Some of the more prestigious facilities and colleges are stepping back from the serotonin hypothesis, largely as a result of being outed by the anti-psychiatry movement. But the diagnostic criteria are still the same, and the treatment hasnt changed. Its still eat these pills every day and come back in three months. And if that doesnt work, well try electric shocks.

Sometimes people feel trapped in their circumstances and are unable to muster the resources or skills to effect the necessary changes. An abused wife, for instance, might lack the economic or emotional means to leave her abusive husband. A man stuck in a job that he hates might not be able to see a way out. In cases like these, the depression can appear permanent and unrelenting. What people in these kinds of circumstances need is genuine help to identify the nature of the issues, generate positive targets, and begin the process of change. An abused wife needs a safe home for herself and her children, an effective safety network, and ongoing emotional and practical support. She does not need a diagnosis of major depressive disorder and a bottle of serotonin reuptake inhibitors.

Drugging a perfectly effective depression mechanism out of existence in order to reduce the immediate sense of discomfort and misery is a bit like sticking duct tape over the check engine light on ones dashboard. It may reduce ones negative feelings on the matter, but will produce no lasting benefits. Physicians who participate in these pharma-sponsored activities are not practicing medicine in any true sense of the term. Rather, they are drug pushers, pure and simple.

Dr. Kendler is proposing that psychiatry abandon the search for monocausal explanations of psychiatric illness and embrace the multicausal perspective. His reasoning is that this is a better perspective and is more in tune with present-day approaches to chronic non-communicable illnesses.

But he has perhaps revealed his true motivation in the 2016 paper:

In our ongoing project to study and justify the nature of psychiatric disorders, we ought to be broadly pragmatic but not lose sight of an underlying commitment, despite the associated difficulties, to the reality of psychiatric illness. (p 5)

In this very clear statement, Dr. Kendler is acknowledging an ongoing and underlying commitment to justify psychiatric disorders and to affirm their reality. But isnt this the very antithesis of science? Isnt it a fundamental requirement of science that we leave our beliefsno matter how deeply cherishedat the door, and go where the science takes us? How much credence should we afford a scholar who acknowledges, apparently without compunction, that in his work and writings his agenda includes an underlying commitment to the reality of psychiatric illness?

Read more from the original source:
The Chemical Imbalance Theory of Depression: Where Is It Going? - James Moore

Read More...

Using isotopes to reconstruct life histories within the transatlantic slave trade – UC Santa Cruz

February 18th, 2020 5:53 pm

"We know villages were destroyed and people were being taken," says Vicky Oelze. "We want to put numbers on it. I'm interested in individual histories." (Photo by Fred Deakin)

This geological map of equatorial Africa shows strontium isotope sampling locations Oelze's team will use to create the first-ever strontium isotope map of the region, a tool researchers will use to help trace the origins of Africans who were abducted during the transatlantic slave trade. (Map courtesy of Vicky Oelze)

Vicky Oelze, an assistant professor of anthropology, should introduce herself as a detective. Who else would attempt to fill in the gaps of the transatlantic slave trade by gathering clues from cemeteries in South Carolina and the shores of West Africa?

Four hundred years after the forced displacement of millions of Africans began, Oelze wants to use isotope biogeochemistry to trace back and identify the origins of individuals who were abducted and perished in the Americas.

Skeletal remains of slaves hold the clues that Oelze will use to identify where in Africa individuals were born and raisedinformation that has been lost to history.

"The narrative we have now is based on log books written by people who were deporting hundreds of Africans on ships," said Oelze. "They documented only the numbershow many left and how many arrived in the respective harbors. There was no recordkeeping of where people were actually from."

Archaeologists have had great success in parts of the developed Western world using strontium isotopes to identify the geological origin of prehistoric people, matching data to detailed strontium isotope maps researchers have developed. This type of map does not exist for tropical Africa, a gap Oelze will fill with over 400 environmental samples from 40 field sites that cover most major geological formations in tropical Africa. The principle is simple: Vegetation takes up a specific isotopic makeup of the trace element strontium from bedrock, and, in tiny quantities, that isotopic "signature" becomes locked in the teeth of people and animals that consume it. Oelze will use samples of African flora and fauna to build a strontium isotope map to match the signatures in skeletal remains of slaves to specific regions in Africa.

With support from the Helen and Will Webster Foundation, Oelze is hiring a postdoctoral researcher for two years to work in partnership with collaborators at the Max Planck Institute for Evolutionary Anthropology in Germany. In a second step, the team will start examining human remains from the Americas for their strontium isotope values. Strontium isotope analysis is particularly valuable when deterioration of skeletal material has ruled out genetic analyses as an option, and it is a much more precise way to assess human mobility on an individual, rather than population, level, said Oelze. The team will also analyze human remains from urban centers of the West African slave trade in collaboration with UCSC archaeologist Cameron Monroe.

"We know villages were destroyed and people were being taken," said Oelze. "We want to put numbers on it. I'm interested in individual histories."

The remains of millions of slaves are buried in designated slave cemeteries and near slave trade centers in the Caribbean and the Americas, as well as in informal burial plots that have been lost to history, noted Oelze. "It is imperative to include descendant communities in the process, she said. Many have a genuine interest in their ancestors. It's important to them, which is why so many are turning to 23andMe."

However, genetics from Africa are postcolonial and therefore flawed, said Oelze. As people were displaced by the pressures of slave raids, they effectively erased their geographic origins; strontium isotope analysis holds the promise of retracing movements from the past, she said.

Oelze's results will also aid wildlife conservation. "Trafficking of endangered animals is of growing concern to conservation, and this map of strontium isotopes in tropical Africa will help identify hotspots of illegal poaching activity," said Oelze, who plans to share her data internationally in open-access publications. She is also eager to use the findings to spark interest in STEM fields among students from Historically Black Colleges and from high schools with diverse student populations.

A hub of excellence

UC Santa Cruz has the potential to lead the field in tracing the histories, geographies, and molecular archaeology of the slave trade, according to Katharyne Mitchell, dean of the Division of Social Sciences. In Anthropology, Lars Fehren-Schmitz brings expertise in the analysis of ancient DNA, and Monroe has conducted extensive research in Bnin and Togo on the transformation of West African communities during the slave trade, as well as related archaeological research in the Caribbean. In History, Professor Greg O'Malley has done pathbreaking work on the transatlantic slave trade.

"This cohort of brilliant scholars is doing transformational work," said Mitchell. "Vicky is a powerhouse, and I'm delighted the Webster family wanted to support her research. I see great things emerging from this."

Oelze, who joined the faculty in 2016 from the Max Planck Institute for Evolutionary Anthropology, will organize a symposium on campus on the molecular forensics of the transatlantic slave trade, drawing historians, archaeologists, isotope geochemists, and geneticists to campus.

Read this article:
Using isotopes to reconstruct life histories within the transatlantic slave trade - UC Santa Cruz

Read More...

Transplanting the immune system: Easier on patients than medication? – WNDU-TV

February 18th, 2020 5:52 pm

There are nearly 35,000 organ transplants done in the U.S. every year. Once patients receive their transplant, they face a lifetime of medications that keep their body from rejecting the new organ, but those medications can cause serious side effects.

Now, a groundbreaking procedure has successfully changed that for one woman.

Having breakfast together was nearly impossible for Barb Okey and her husband after her kidney transplant. The 24 pills she took before breakfast ruined her appetite, and the side effects left her tired. But that's all in the past now.

In 27 years doing transplants, Dr. Dixon Kaufman has never done one like Barb's. Her sister's kidney was a perfect match, but then both women took part in a second pioneering transplant to give Barb her sister's immune system.

"We had the transplant and the next day I started radiation. I had to do radiation for 10 days," Barb recalled. "That was to suppress my immune system. After the 10th day, they gave me my sister's stem cells."

"The immune cells start to multiply, so she has not only the kidney from her sister but a little bit of her sister's immune system, and we call that phenomenon chimerism a,nd that's where you have a dual immune system," Kaufman said.

The immunity accepted the new kidney and left Barb drug-free.

"It's the start of hopefully a long progression of trials that will allow more and more people to, if not completely eliminate the medicines, significantly reduce them," Kaufman said.

"I feel very, very lucky. Very lucky," Barb said.

Barb is just the second person in the U.S. to take part in the national trial pioneering the duel transplant. The hope is that the procedure will one day be available to transplant recipients who are not perfect matches with their donors, and possibly even to those who have had transplants in the past.

MEDICAL BREAKTHROUGHSRESEARCH SUMMARYTOPIC: TRANSPLANTING THE IMMUNE SYSTEM: EASIER ON PATIENTS?REPORT: MB #4700

BACKGROUND: Organ transplantation is sometimes necessary when one of a patient's organs has failed. This can happen because of injury or illness. The organ may come from a living donor or one who has died. Transplants can include heart, intestine, kidney, liver, lung, or pancreas. Often patients must wait a long time for an organ transplant and doctors must match donors to recipients to reduce the risk of transplant rejection. (Source: https://medlineplus.gov/organtransplantation.html)

REJECTION RISK: The immune system usually protects you from substances that may be harmful, but it can also simply attack anything that enters the body, which the immune system detects as "foreign", and this includes transplanted organs. When a person receives an organ in transplant surgery, their immune system may recognize that it is foreign if the cells of the organ are different or "not matched". Mismatched organs can trigger a blood transfusion reaction or transplant rejection. To help prevent this rejection, doctors try their best to match similar proteins known as antigens between the donor and recipient. Tissue typing ensures the organ or tissue is as similar as possible to the recipient's tissue. The match is usually not perfect, as only identical twins have identical tissue antigens. Doctors use medicines to suppress the recipient's immune system with the goal of preventing it from attacking the newly transplanted organ. If these medicines are not used, the body will almost always launch an immune response and destroy the foreign tissue. Some exceptions include cornea transplants, because the cornea has no blood supply. Also, transplants from one identical twin to another are almost never rejected. (Source: https://medlineplus.gov/ency/article/000815.htm)

NEW RESEARCH: Medeor Therapeutics is now developing cell-based therapy to reprogram an organ recipient's immune system to accept the transplanted kidney without the need for long-term use of immune system suppressing drugs. The study is in Phase 3 and is working to demonstrate the efficacy and safety of how transplanting some of the stem cells from the organ donor into the organ recipient after transplant surgery could cause an immune tolerance; preserving the organ donation and preventing kidney transplant rejection. It would also eliminate the need for immunosuppressive drugs for the rest of the patient's life. (Source: https://clinicaltrials.gov/ct2/show/study/NCT03363945?show_locs=Y#locn)

See the article here:
Transplanting the immune system: Easier on patients than medication? - WNDU-TV

Read More...

MS: Dietary interventions may calm down the immune system – Medical News Today

February 18th, 2020 5:52 pm

A study in mice has shown that a change in diet may slow diseases that involve the activation of the immune system, such as multiple sclerosis (MS). Could the findings lead to improved treatments in humans?

In the United States, nearly 1 million people over the age of 18 are living with a diagnosis of MS, according to estimates.

MS is the most common of the inflammatory disorders with an autoimmune component, which refers to the immune system attacking and damaging healthy tissue.

In MS, the immune system attacks the myelin sheaths that protect the nerve cells in the brain and spinal cord, disrupting nerves messages to and from the brain.

The result can involve muscle weakness, numbness, trouble with balance and coordination, and cognitive decline, all of which get worse over time.

Doctors most frequently diagnose MS in young adults, although the diagnosis can be made at any age.

At present, no medical treatment can prevent or slow MS without greatly increasing the risk of infection or cancer. But what if dietary changes could delay the diseases onset and progression in high risk individuals?

Researchers have recently explored the role of methionine, an amino acid, in the overactive inflammatory response of conditions such as MS.

The teams results now appear in the journal Cell Metabolism.

While methionine is essential to a healthy immune system, it has an adverse effect on people at risk of autoimmune disease.

Russell Jones, Ph.D., of the Van Andel Institute, in Grand Rapids, Michigan, is the studys senior author. He comments on the findings, explaining:

Our results suggest [that] for people predisposed to inflammatory and autoimmune disorders like multiple sclerosis, reducing methionine intake can actually dampen the immune cells that cause disease, leading to better outcomes.

Many types of cell throughout the body produce methionine, a building block of protein and a form of fuel.

Defensive immune cells that respond to threats called T cells do not produce their own methionine and instead rely on dietary sources.

Certain animal products, such as meat and eggs, have especially high amounts of methionine.

One of the ways that the body defends itself against threats such as pathogens, or germs, is by flooding the affected area with T cells.

The researchers found that ingested methionine added fuel to this process by helping the T cells replicate and branch into specialized subtypes quicker.

However, once boosted by methionine, some of these reprogrammed T cells caused inflammation or swelling.

This is usually a healthy immune response, but if the swelling persists, it can cause damage such as that which characterizes MS.

The scientists found that dramatically lowering the amount of methionine in the diet of mice with induced MS changed the reprogramming of their T cells and limited the cells ability to cause swelling in the brain and spinal cord.

This, in turn, slowed the diseases progression.

These findings provide further basis for dietary interventions as future treatments for these disorders, Jones notes.

By restricting methionine in the diet, youre essentially removing the fuel for this overactive inflammatory response without compromising the rest of the immune system. Russell Jones, Ph.D.

However, before dietary guidelines can be established, researchers must prove that humans also experience these effects.

At present, there is no comprehensive understanding of the cause of MS, although genes related to the immune system play a role, as do environmental and metabolic factors, such as obesity.

The fact that metabolic factors like obesity increase the risk of developing multiple sclerosis makes the idea of dietary intervention to calm down the immune system particularly appealing, says co-author Catherine Larochelle, Ph.D., of the University of Montreal, in Canada.

The researchers will also investigate the possibility of creating new medications to target methionine metabolism.

The present study is only the latest to explore the role of dietary methionine limitation in disease treatment.

In 2019, a study from the Locasale Lab, at Duke University, in Durham, NC, showed that the cancer-fighting effects of chemotherapy and radiation could be improved by reducing methionine intake.

Link:
MS: Dietary interventions may calm down the immune system - Medical News Today

Read More...

New research: Vaping weakens fight against infections – Grand Forks Herald

February 18th, 2020 5:52 pm

SIOUX FALLS, S.D. E-cigarettes are often portrayed as safer than cigarettes. But a new study indicates the use of e-cigarettes, or vaping, makes it harder to fight infections whether or not the e-cigarette contains nicotine.

Vaping weakens cells in the body that are crucial to the fight against infections, according to the laboratory study by researchers at Veterans Affairs San Diego Healthcare System and the University of California San Diego, published earlier this month in the American Journal of Physiology-Cell Physiology.

The negative effect on the cells known as neutrophils, a type of white blood cell, was similar to that experienced when they are exposed to environmental toxins such as cigarette smoke, the researchers found in the study conducted on both humans and mice.

The study adds to the body of research showing that vaping's reputation as a safer alternative to smoking may be less true than many believe. Based on the findings, Dr. Laura E. Crotty Alexander of VA San Diego and University of California San Diego and the corresponding author on the paper, cautioned against using e-cigarettes.

We recommend that vaping be avoided in general, as our data and other findings demonstrate multiple possible adverse health effects caused by the use of e-cigarette and vaping devices," she said.

The research was conducted by exposing human neutrophil cells to e-cigarette vapor, a practice later confirmed on mice. It shows vaping limited neutrophils ability to get to the site of an infection, fight it once they arrived and produce compounds that fight bacteria.

Crotty Alexander said that based on the lab findings, it appears that the key chemicals that immune cells are exposed to during vaping cause dysfunction and thus weaken the immune system.

Further work by the researchers will focus on how the amount or style of vaping affects the immune system.

About 3% of American adults, approximately 7 million people, use e-cigarettes, according to a 2017 study. But youth and young adults are taking up the practice at a much higher rate, according to a 2016 U.S. Surgeon General report.

The emergence last year of a vaping related respiratory illness that sickened thousands and killed dozens drew a harsh spotlight to the potential risks of vaping.

Federal and state officials continue to investigate the illness, tentatively linked to the inclusion of vitamin E acetate within some e-cigarette fluids. Partly in response to the wave of illnesses, the Trump administration banned a range of vape liquid flavors and speedily approved legislation that raised the age of those allowed to buy both tobacco and vaping products that contain nicotine from 18 to 21.

Read more here:
New research: Vaping weakens fight against infections - Grand Forks Herald

Read More...

Patient health, flu myths, and signs of a strong immune system – Chiropractic Economics

February 18th, 2020 5:52 pm

Chiropractic Economics February 12, 2020

Health care experts in the wellness field are scrambling to keep patients well during a hard-hitting flu season and additional worries about a new coronavirus.

Keeping patients immune system in top shape with the signs of a strong immune system, experts say, is a way to combat both.

More than 12,000 adults and 78 children have died during this flu season according to the weekly flu report from the Centers for Disease Control and Prevention (CDC). While the coronavirus has dominated the headlines, the flu is much more likely to impact Americans and should be the main concern saysLibby Richards, an associate professor of nursing in PurduesSchool of Nursing.

Its important to keep in mind that while we currently do not have a vaccine for coronavirus, we do have a safe and effective vaccine for the flu, and its not too late to get one, Richards says. We are still in the peak of flu season, so vaccination is important to protect you and those around you. The flu vaccine helps protect not only you from influenza but can also lessen your chance of flu-related complications.

According to Purdue University doctors, adults and children need to be fever-free for 24 hours without the assistance of over-the-counter or prescription medications before they can return to work or school. Its also never too late to get a flu shot.

Eating right, maintaining a healthy lifestyle and getting enough sleep are some of the primary drivers of and signs of a strong immune system.

This season the CDC estimates that 9.7 million cases of the flu have been thus far diagnosed.

Also along the lines of creating or maintaining a healthy immune system for patients includes maintaining a healthy weight, eating plenty of fruits and vegetables, drinking plenty of fluids, meeting physical activity guidelines, not smoking, and limiting alcohol consumption and stress.

Seven to nine hours of sleep is recommended when you are feeling sick, as well as when you are healthy, Richards said. In addition to getting adequate sleep when ill, it is also important to rest during the day and try to avoid overexertion.

If you have a productive cough, do everyone a favor and avoid the gym. Staying home is a perfect way to not spread germs. If you have mild cold symptoms and you feel you have the energy to exercise, go for it as exercise might help you feel better, but consider reducing the duration or intensity of your exercise. If you are having fatigue, body aches, stomach issues, you should stay home and rest as exercise could increase your chance of an injury.

When it comes to children, Richards says, keep washing everyones hands.

Kids touch everything, which is one big way germs are spread, she says. Kids also tend not to understand or value what personal space is and can be in each others faces all the time. Parents, teachers and caregivers can demonstrate proper hand-washing and cough hygiene all year long not just during flu season[And] as much as we love to show affection with kisses, its possible to spread the flu one to three days prior to the start of symptoms.

The human immune system fights off infection, disease, viruses and more. But if the immune system protects you, why do you get sick?

The immune system (tonsils, lymph nodes, lymph vessels, thymus gland and bone marrow) consists of the lymphatic system, and your skin and mucus membranes act as the first line of defense, according to Roswell Park, the U.S.s first cancer center. The skin presents the physical barrier, while the mucus membranes that line your bodys openings make and release substances that repel invaders.

Vaccines work with your bodys natural defenses to create immunity to a specific disease, writes Roswell Park. Long ago, people realized that survivors of a disease didnt get that disease again. A British doctor is often credited with the first vaccine (for smallpox) in the 1790s, but a Chinese emperor who was a smallpox survivor himself started an inoculation program against the disease in the mid-1600s.

When someone with the flu coughs or sneezes, flu germs enter the air and are breathed in by other potential carriers. Will they get sick? What are their signs of a strong immune system? It depends on:

There still remains a common mis-perception among patients that they can get the flu by getting a flu shot. This myth leads to the spreading of the flu by un-vaccinated individuals.

The flu vaccine contains an inactive virus and gives the body a preview of what to look for and how to fight it off. Sometimes individuals can feel effects after a flu shot due to the body creating an immune response, as it should. Headaches or low-grade fevers are not out of the ordinary and are sometimes mistaken for the flu but are just natural responses from the body.

The flu season can go well into May, and individuals age 6 and up should get the flu shot which traditionally protects against influenza A (H1N1) and (H3N2), and the influenza B virus. For additional flu info from the CDC go to cdc.gov/flu/index.htm.

Read more from the original source:
Patient health, flu myths, and signs of a strong immune system - Chiropractic Economics

Read More...

How Patients Die After Contracting COVID-19, The New Coronavirus Disease : Goats and Soda – NPR

February 18th, 2020 5:52 pm

A doctor wearing a face mask looks at a CT image of a lung of a patient at a hospital in Wuhan, China. AFP via Getty Images hide caption

A doctor wearing a face mask looks at a CT image of a lung of a patient at a hospital in Wuhan, China.

More than 1,300 people, almost all in China, have now died from COVID-19 the newly minted name for the coronavirus disease first identified in Wuhan, China, that has infected more than 55,000 people.

Yet according to the World Health Organization, the disease is relatively mild in about 80% of cases, based on preliminary data from China.

What does mild mean?

And how does this disease turn fatal?

The first symptoms of COVID-19 are pretty common with respiratory illnesses fever, a dry cough and shortness of breath, says Dr. Carlos del Rio, a professor of medicine and global health at Emory University who has consulted with colleagues treating coronavirus patients in China and Germany. "Some people also get a headache, sore throat," he says. Fatigue has also been reported and less commonly, diarrhea. It may feel as if you have a cold. Or you may feel that flu-like feeling of being hit by a train.

Doctors say these patients with milder symptoms should check in with their physician to make sure their symptoms don't progress to something more serious, but they don't require major medical intervention.

But the new coronavirus attacks the lungs, and in about 20% of patients, infections can get more serious. As the virus enters lung cells, it starts to replicate, destroying the cells, explains Dr. Yoko Furuya, an infectious disease specialist at Columbia University Irving Medical Center.

"Because our body senses all of those viruses as basically foreign invaders, that triggers our immune system to sweep in and try to contain and control the virus and stop it from making more and more copies of itself," she says.

But Furuya says that this immune system response to this invader can also destroy lung tissue and cause inflammation. The end result can be pneumonia. That means the air sacs in the lungs become inflamed and filled with fluid, making it harder to breathe.

Del Rio says that these symptoms can also make it harder for the lungs to get oxygen to your blood, potentially triggering a cascade of problems. "The lack of oxygen leads to more inflammation, more problems in the body. Organs need oxygen to function, right? So when you don't have oxygen there, then your liver dies and your kidney dies," he says.

That's what seems to be happening in the most severe cases. About 3% to 5% of patients end up in intensive care, according to the WHO. And many hospitalized patients require supplemental oxygen. In extreme cases, they need mechanical ventilation including the use of a sophisticated technology known as ECMO (extracorporeal membrane oxygenation), which basically acts as the patient's lungs, adding oxygen to their blood and removing carbon dioxide. The technology "allows us to save more severe patients," Dr. Sylvie Briand, director of the WHO's pandemic and epidemic diseases department, said at a press conference Monday.

Many of the more serious cases have been in people who are middle-aged and elderly Furuya notes that our immune system gets weaker as we age. She says for long-term smokers, it could be even worse because their airways and lungs are more vulnerable. People with other underlying medical conditions, such as heart disease, diabetes or chronic lung disease, have also proved most vulnerable. Furuya says those kinds of conditions can make it harder for the body to recover from infections.

"Of course, you have outliers people who are young and otherwise previously healthy who are dying," Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently told NPR's 1A show. "But if you look at the vast majority of the people who have serious disease and who will ultimately die, they are in that group that are either elderly and/or have underlying conditions."

The WHO has said most deaths so far appear to be from multi-organ failure and has calculated the case fatality rate at about 2% or less, based on earlier data from China. However, infectious disease experts note that it's hard to know the true numbers at this point in the epidemic.

But del Rio notes that it's not just COVID-19 that can bring on multi-organ failure. Just last month, he saw the same thing in a previously healthy flu patient in the U.S. who had not gotten a flu shot.

"He went in to a doctor. They said, 'You have the flu don't worry.' He went home. Two days later, he was in the ER. Five days later, he was very sick and in the ICU" with organ failure, del Rio says. While it's possible for patients who reach this stage to survive, recovery can take many weeks or months.

In fact, many infectious disease experts have been making comparisons between this new coronavirus and the flu and common cold, because it appears to be highly transmissible.

"What this is acting like it's spreading much more rapidly than SARS [severe acute respiratory syndrome], the other coronavirus, but the fatality rate is much less," Fauci told 1A. "It's acting much more like a really bad influenza."

What experts fear is that, like the flu, COVID-19 will keep coming back year after year.

Originally posted here:
How Patients Die After Contracting COVID-19, The New Coronavirus Disease : Goats and Soda - NPR

Read More...

Page 675«..1020..674675676677..680690..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick